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ABSTRACT
Aminolevulinic acid synthase- l (ALAS- I) is the first and normally
rate-controlling enzyme for hepatic heme biosynthesis. ALAS- l is highly
inducible , especially in liver, in response to changes in nutrtional status , and
to drugs that induce cytochrome P-450. The critical biochemical abnormality
of the acute porphyrias , a group of disorders of heme synthesis, is an
uncontrolled up-regulation of ALAS- I. High intakes of glucose or other
metabolizable sugars and intravenous heme are the cornerstones of therapy
for acute attacks of porphyrias and both repress the over-expression ALAS-
, although their mechanisms of action have not been fully characterized.
In this work, the chick hepatoma cell line, LMH, was characterized
with respect to its usefulness in studies of heme biosynthesis and compared
with chick embryo liver cells (CELCs), a widely used model for studies of
heme metabolism. The inducibility of ALAS- I mRA and enzyme activity
and accumulation of porphyrins by chemicals were used to evaluate heme
biosynthesis in LMH cells. Repression of ALAS- l mRA and induced
activity by exogenous heme (20 
IlM) was shown to occur in LMH cells as in
CELCs. In addition, a synergistic induction of ALAS- l enzye activity was
observed in LMH cells , as shown previously in CELCs , by treatment with a
barbiturate-like chemical , Glutethimide (Glut), in combination with an
inhibitor of heme synthesis , 4 dioxoheptanoic acid (DHA). This induction
of ALAS- l enze activity is analogous to what occurs in patients with
acute hepatic porphyrias and LMH cells were used to further characterize
effects of Glut, DHA, glucose, and heme on ALAS-
A "glucose effect" to decrease Glut and DHA-induced ALAS-
enzyme activity was obtained in LMH cells and CELCs in the absence of
serum or hormones. This "glucose effect" was further characterized in LMH
cells using a constrct containing approximately 9. 1 kb of chick ALAS- l S'
flanking and S' -UTR region attached to a luciferase/reporter gene
(pGcALAS9. Luc). Glut (SO 
IlM) and DHA (2S0 IlM) synergistically
induced luciferase activity (S-fold) in LMH cells transiently transfected with
pGcALAS9.1-Luc. Addition of glucose (11 or 33 mM), in a dose-dependent
manner, decreased the Glut+DHA up-regulation ofpGcALAS9.1-Luc
activity. Gluconeogenic or glycolytic substrates such as frctose
, galactose
glycerol and lactate, but not the non-metabolizable sugar sorbitol , also
down-regulated pGcALAS9. Luc in LMH cells. The cAMP analog 8-CPT-
cAMP, augmented Glut induction of ALAS- , indicating that the glucose
effect may be partly mediated by changes in cAMP levels.
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The remaining studies focused on delineating the synergistic effect of
Glut and DHA, and heme-dependent repression of ALAS- I. The 9. 1 kb
constrct was compared with a constrct containing the first 3.S kb
(pGcALAS3. Luc). The drg and heme effects were shown to be separate
as drug induction was present in -3.4 to +0.082 kb region while the heme
responsiveness was present in the - 1 to -3.4 kb region. Using computer
sequence analysis, several consensus activator protein- l (AP- l) sites were
found in the 9. 1 kb ALAS- l sequence but no consensus direct repeat (DR)-
or DR- tye recognition sequences for nuclear receptors were identified in
the drg-responsive 3.S kb region. Deletion constrcts containing +0.082 to
6 kb (pGcALAS7. Luc) and +0.082 to - 2 kb (pGcALAS6. Luc)
cALAS S' flanking and S' UTR region were generated and tested and
pGcALAS6. Luc was shown to have heme-dependent repression of basal
and Glut and DHA- induced activity.
A recently identified 167 bp chick ALAS- l drg responsive enhancer
(DRE) was PCR amplified and inserted upstream of the 9. 1 kb
(pGcALAS9. 1+DRE), a 0.399 kb (+0.082 to - 317) (pGcALASO.3+DRE),
and pGL3SV40 constrct (pGL3SV40+DRE). DRE mediated the up-
regulation ofpGL3SV40+DRE constrct by Glut was IS-30 fold but
Vll
interestingly only 3.2 and 3. fold for pGcALAS9. +DRE and
pGcALASO.3+DRE constrcts , respectively.
In summary, in LMH cells drugs up-regulate ALAS- l through non-
DRE element(s) in the first 3.5 kb of ALAS- l 5' flanking and 5' UTR
region and heme down regulates ALAS- l and determnes the extent of the
drug response through element(s) in the - 3 to - 5 kb region of ALAS- l 5'
flanking region.
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CHAPTER I
INTRODUCTION AND OBJECTIVES
Introduction
Heme is essential for the health and function of nearly all cells , acting
predominantly as a prosthetic group for oxygen-carring proteins and
enzyes involved in oxidation/reduction or electron transport reactions.
Heme biosynthesis is a multi-step pathway that is present in virtally all cell
tyes. In eukaryotes , eryhroid cells and hepatocytes are the major sites of
heme biosynthesis (Ades 1990), 5-Aminolevulinate synthase (Succinyl-
CoA:GlycineC-Succinyl transferase, E,C. 2. 37) (ALA synthase or
ALAS) is the first and rate-controllng enze in the heme biosynthetic
pathway in animals (May et aI. , 1986). ALAS is a pyridoxal 5' -phosphate-
dependent enzye that exists as a homodimer in the mitochondrial matrix
where it catalyzes the condensation of glycine and succinyl CoA to form 5"'
aminolevulinate (ALA) (Kappas et aI. , 2000). In mammals and birds , ALAS
is encoded by 2 genes: ALAS- , which is expressed ubiquitously, and
ALAS- , which is expressed only in eryhrocytes and eryhroid precursors
(Riddle et aI. , 1989; Bishop et aI. , 1990; May et aI. , 1995) (Figure 1.1).
Figure 1. 1. Schematic diagram of the hepatic heme biosynthetic
pathway. ALAS- l catalyses the formation of ALA from glycine and
succinyl CoA using pyridoxal 5' -phosphate (PLP) as a cofactor. ALA is
converted through a series of steps catalyzed by enzyes (in italics) in the
mitochondrion or the cytoplasm into heme. Heme synthesis begins and ends
in the mitochondrion. Heme is incorporated into apo-hemoproteins
(cytochromes shown) to form functional holo-hemoproteins. ALA, 5-
aminolevulinic acid; PBG, porphobilinogen; HMB , hydroxymethyl bilane;
URO' GEN, uroporphyrinogen III; COPRO' GEN, coproporphyrinogen;
PROTO' GEN, protoporphyrinogen; and PROTO, protoporphyrin.
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Defects in heme synthesis and metabolism may have far-reaching
pathological and biochemical effects, For example, the porphyrias (to be
discussed on p, 17) are a group of diseases in which there are defects in
normal heme synthesis, with elevated levels of ALAS- , and overproduction
of heme precursors occurrng during acute attacks (Kappas et aI. , 1989;
Bonkovsky et aI. , 1990). Insufficient supply of heme may affect levels and
activities of key cellular hemoproteins, including mitochondral
cytochromes, catalase, trtophan pyrolase, and cytochrome P-450s (CYP)
and b5. These latter cytochromes playa key role in the metabolism of many
endogenous and exogenous compounds, including lipophilic drugs, toxins
carcinogens , steroids, prostaglandins and inflammatory mediators (Coon et
aI. , 1992; Guengerich 1992; Nebert and Russell , 2002) and are induced by
the lipophilic substances they metabolize (Okey 1990).
Induction of ALAS- l by chemicals: Chemicals can induce ALAS-
by more than one means. A general mechanism of induction of ALAS- 1 by
chemicals is thought to be by the depletion ofa small, but critical , pool of
heme within hepatocytes (Granick et aI.
, 1975) (See The Regulatory Heme
Pool). Recent studies (Fraser et aI. , 2002 and Fraser et aI. , 2003), in chick
hepatoma (LMH) cells, demonstrate that certain lipophilic drugs can act
directly to increase transcription of the ALAS- l gene, as summarized below
(see Chemicals that induce CYP)
Chemicals that induce ALAS- l by increasing heme degradation
Porphyrogenic chemicals (chemicals that lead to an increase in
porphyrinogens) such as 2-allyl- isopropylacetamide (AlA) increase
ALAS- l activity by depleting the heme pool by increasing the breakdown of
heme to non-physiological products (De Matteis et aI. , 1977), while others
such as the combination of glutethimide (Glut) and ferric nitrlotriacetate
(FeNT A), have been shown to do this by inducing the normal pathway for
heme degradation via the enzye heme oxygenase- l (HO- l) in chick
embryo liver cells (CELCs) (Lincoln et aI. , 1988; Cable et aI. , 1991).
Chemicals that induce ALAS- l by inhibiting heme biosynthesis:
Another mechanism for the depletion of heme is by inhibition of normal
heme synthesis (Kappas et aI. , 2000), For example, 4 dioxoheptanoic acid
(DHA) and deferoxamine (DFO) are inhibitors of ALA dehydratase (the
second enzyme in the heme biosynthetic pathway) and ferrochelatase (the
terminal enzye of the pathway), respectively (Figure 1. 1), However, even
profound inhibition of the heme biosynthetic pathway per se is not able to
produce a marked induction (2 5 fold) of ALAS- l activity in CELCs (Giger
and Meyer 1983). Such induction requires the presence of lipophilic
chemicals that act directly to increase production of the synthase as
r-j
discussed below and/or to increase the demand for heme by the synthesis of
new molecules ofCYP(s) (May et aI. , 1986; Kappas et aI. , 2000).
Chemicals that induce CYP: CYP(s) are a super family of proteins
that are now believed to include 57 genes (Nebert and Russell 2002). CYPs
utilize most (~60%) of the heme that is synthesized in the liver (hereafter
termed endogenous heme) for assembly into holocytochrome P450(s)
(Kappas et aI. , 2000) (Figure 1. 1), ALAS- l expression and heme levels are
increased by. drgs and other chemical inducers ofCYP apoproteins (May et
aI. , 1995; Lindberg et aI. , 1996; Jover et aI. , 2000).
Chemicals that induce CYPs were thought to also increase ALAS-
expression indirectly by heme-dependent mechanisms (Srivastava et aI.
1980; Kappas et aI. , 2000) (Figure 1.2). Experimental results with
phenobarbital (PB), and other porphyrinogenic chemicals , demonstrated an
increase in CYP and ALAS- l activity (De Matteis and Gibbs, 1972; Giger
f.'
and Meyer, 1981), and induction of apohemoproteins was envisioned to first
cause an increase in demand for heme, thereby leading to a depletion of the
Figure 1.2. Effects of the regulatory heme pool on hepatic heme
metabolism. Heme exerts regulatory effects on both ALAS- l and HO- l to
control both its synthesis and degradation. ALAS- l catalyses the formation
of ALA, from glycine and succinyl CoA, which then through a series of
intermediary steps catalyzed by the enzyes of the heme biosynthetic
pathway, forms heme (Figure 1, 1), Several steps in the production of
functional mature ALAS- l protein are modulated by exogenous or
endogenous heme as indicated by the minus signs
, or by the plus sign
indicating increased degradation of ALAS- l mRA. Regulatory heme is
incorporated into apo-hemoproteins (such as CYPs and mitochondrial
cytochromes) as the prosthetic group to form functional holo-hemoproteins.
Heme increases transcription of HO- , leading to increased production of
HO- l protein, which catalyzes heme degradation,
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heme pool followed by an induction of ALAS- l (Kappas et aI. , 2000)
(Figure 1.2). However, further experiments in CELCs investigating the
relationship between induction of CYP2HI and ALAS- l have shown that
mRAs for CYP2Hl and ALAS- l were simultaneously increased after
treatment with PB-like drugs , and that inhibitors of heme synthesis had little
or no effect on ALAS- l mRA expression (Hamilton et aI. , 1988),
Overexpression of a CYP protein in primary chick cells to levels similar to
those achieved following induction by PB (presumably to deplete the heme
pool) was shown not to result in ALAS- l induction (Jover et aI. , 1996), The
recent discovery that orphan nuclear receptors (members of a super family of
transcription factors) mediate drg induction of CYP2H 1 (Hands chin and
Meyer, 2000) and ALAS- l (Fraser et aI. , 2002) and the isolation of a chick
xenobiotic nuclear receptor (CXR) (Hands chin et aI. , 2000) that mediates
this induction give further support for the direct effect of drugs on ALAS-
These studies indicate that ALAS- l gene expression can be increased
directly by chemicals, However, the effect of the regulatory heme pool on
induction of ALAS- l by drugs has remained unclear ftom the above studies,
This is partly because the regulatory heme pool is known to be rapidly
turned over (see The Regulatory Heme Pool), making it hard to determne
I _1 . the extent of depletion of the heme pool in a particular cell (Kappas et aI.
2000).
In spite of these limitations, indirect evidence for the heme pool
hypothesis has been obtained from heme-deficient animal models and from
cells treated with chemicals that affect heme synthesis (Sassa and Kappas
1982; Lukton et aI. , 1988; Brady and Lock. , 1992; Kolluri et aI. , 1999; Jover
et aI. , 2000). A recent study in normal and heme-deficient mice showed that
PB treatment increases hepatic ALAS- l mRA, supporting the concept that
PB directly affects ALAS- l expression (Jover et aI. , 2000). In the same
study, mice that were deficient in heme synthesis (PBGD-deficient mice)
had a synergistic increase in ALAS- mRA levels in response to PB , as
compared to normal mice (Jover et aI.
, 2000). The synergistic increase of
ALAS- l mRA by drgs in the above described heme-deficient animal
model involved repetitive doses ofPB (that also induces CYP) (Jover et aI.
2000) suggesting that heme-deficiency can augment drg-induction of
ALAS-
Regulation of ALAS- l by heme: As mentioned before, heme
functions not only as a prosthetic group of oxygen-carring proteins and
enzyes involved in oxidation/reduction or electron transport reactions
, but
also as an important molecule that regulates metabolic pathways (Sassa and
Nagai , 1996). In 1966 , the finding by Granick et aI. , that heme negatively
regulates its own biosynthesis by modulating the production of ALAS-
l in
the liver, was a seminal demonstration of feedback regulation by the end-
product of the first enze in the pathway. Since then it has been shown that
heme negatively regulates ALAS- l by a variety of mechanisms, including
repression of transcription, increased degradation of mRA, and inhibition
of mitochondrial translocation as described below and as summarized in
Figure 1.
Transcriptional repression of the ALAS- I gene: The half-life of the
mRA of hepatic ALAS- l is reported to be short; from 1-5 h (Drew and
Ades, 1989; Hamilton et aI. , 1991). Because of this , transcriptional
repression could be an effective mechanism for regulation of ALAS-
While heme has been shown to up-regulate gene expression by functioning
as a ligand for transcription factors (Creusot et aI.
, 1989; Zhang et aI. , 1998;
Ogawa etaI. , 2001), the molecular mechanism by which heme represses
ALAS- l gene transcription, have remained elusive. In earlier work in intact
rats , it was shown that heme down-regulated transcription of ALAS-
(Srivastava et aI. , 1988; Yamamoto et aI. , 1988; Srivastava et aI. , 1990) and
) -
had no effect on stability of the mRA of ALAS- l (Yamamoto et aI. , 1988).
However, other evidence indicates that heme might be involved in regulation
of ALAS- l mRA stability in primary rat hepatocytes (Cable et aI.
, 2000),
Data from CELCs showed that the effects of heme on ALAS- l could be
accounted for solely by decreasing half-life of the mRA (Drew and Ades
1989; Hamilton et aI. , 1991) without any change in ALAS- l gene
transcription (Hamilton et aI. , 1991). The differences in transcriptional
regulation between chick and other model systems require further
investigation.
Increase of ALAS- l mRA degradation: As just mentioned, in
CELCs the half-life of ALAS- l mRA has been shown to decrease from
180-220 minutes to 70-90 minutes in the presence of heme
, (1- 10 IlM)
(Drew and Ades , 1989; Hamilton et aI. , 1991) without any change in gene
transcription (Hamilton et aI. , 1991). Data from rats , however, showed that
the half-life of the ALAS- l mRA is unchanged in the presence of heme
(Yamamoto et aI. , 1989; Srivastava et aI. , 1990), but ALAS- l gene
transcription is decreased as discussed above. Recent evidence
, however
indicates that heme is involved in the regulation of ALAS- l mRA stability
in primary rat hepatocytes (Cable et aI.
, 2000).
Decrease of mitochondrial import of pre-ALAS- ALAS- l is
encoded in the nuclear genome but fuctions as an enzye in the
mitochondrial matrix (May et aI. , 1995), ALAS- , synthesized in the cytosol
on ribosomes as pre-ALAS- l (Whiting et aI. , 1976), is imported into the
mitochondria (Ohashi et aI. , 1978), Heme inhibits the translocation and
processing of the cytosolic pre-ALAS through heme regulatory motifs
(HRM) in the amino termnal of the pre-ALAS protein (Srivastava et aI.
1983; Hayashi et aI. , 1983; Lathrop and Timko , 1993). Although these
studies described above were carried out with the mouse eryhroid ALAS-
the same sequences exist in ALAS- l (Zhang and Guarente, 1995), rat
hemopexin (Nikkila et aI. , 1991), and the yeast heme activated transcription
factor (HAP 1) (Zhang et aI. , 1998). The existence of this motif in several
heme-regulated proteins suggests that this may be a general mechanism for
regulation by heme.
Summary of regulatory mechanisms: In summary, heme negatively
regulates ALAS- l by a variety of mechanisms including repression of gene
transcription in rats (Srivastava et aI. , 1988), decreasing the half life of
ALAS- l mRA and import of the pre-ALAS- l protein from cytoplasm to
mitochondria in chick cells (Srivastava et aI. , 1983; Hamilton et aI. , 1988).
1,1
Chemicals that induce CYPs , directly and simultaneously increase ALAS-
and CYP mRAs in CELCs and chick hepatoma (LMH) cells (Hamilton et
aI. , 1988; Hamilton et aI. , 1991; Fraser et aI. , 2002). Heme has been shown
to repress ALAS- l gene transcription in rat livers (Yamamoto et aI.
, 1989;
Srivastava et aI. , 1990) but not in chick liver cells (Drew and Ades
, 1989;
Hamilton et aI. , 1991), Finally, a mouse with a targeted disruption ofPBGD
the third enzye of the heme synthesis pathway, showed a synergistic
increase in ALAS- mRA after PB treatment (Jover et aI. , 2000).
However, the molecular mechanism(s) such as the signaling pathways
cis-
acting element(s), or transcription factor complexes by which heme
regulates basal and drug-mediated ALAS- l gene expression have been
largely unexplored.
j O
The Regulatory Heme Pool
The observed effects of heme on ALAS- l led to the formulation of a
concept referred to as the ' regulatory
' '
free , or 'unassigned' heme pool
(Sinclair and Granick, 1975; Granick et aI. , 1975; Kappas et aI. , 1989;
Bonkovsky et aI. , 1990), According to this hypothesis, hepatocytes contain a
small , but crucial, heme pool that fuctions as a barometer of the cell' s heme
requirements (Figue 1,2). Heme is envisioned to exchange between this
pool and the various hemoproteins of the cells (Figure 1.2). The free or
regulatory" heme pool is presumed to be very small
, and rapidly turn-over
(Ketterer et aI. , 1976; Vincent et aI. , 1989; Miiller-eberhard and Fraig 1993),
making it practically impossible to measure to prove/disprove this
hypothesis. There is some indirect evidence for this hypothesis obtained
from heme-deficient animals (Jover et aI. , 2000) and cells in culture, as
described below.
In cultured cells, an increase in the size of the regulatory heme pool
(eg, after administration of exogenous heme) represses ALAS-
l activity
(Hamilton et aI. , 1988; Cable et aI. , 1993; Kolluri et aI. , 1999) and increases
transcription of the HO- l and metallothionein (MT) genes (Alam and Smith
i -
1992; Smith et aI. , 1993; Cable et aI. , 1994). In contrast, conditions that
deplete the regulatory heme pool (e. , drgs in combination with inhibitors
of heme synthesis) tend to synergistically increase activity of ALAS
(Hamilton et aI. , 1988; Russo et aI. , 1994). However, it has been well
established that heme pool depletion per se will not give rise to high (2' 5-
fold) activities of ALAS- l such as those seen in models of acute porphyrias
(Giger and Meyer 1983). Such high induction requires the presence of
lipophilic chemicals in addition to chemicals that affect heme synthesis
(Hamilton et aI. , 1988; Russo et aI. , 1994).
Several studies have suggested that drgs can directly increase ALAS-
I gene expression (Hamilton et aI. , 1988; Fraser et aI. , 2002 and Fraser et aI.
2003), and that simultaneous inhibition of heme synthesis results in
synergistic increases in ALAS- l mRA levels (Sassa and Kappas 1982;
Hamilton et aI. , 1988; Jover et aI. , 2000), However, the effect of the "free
or "regulatory" heme pool on drug-mediated induction of ALAS- l gene
expression has not been demonstrated.
The Porphyrias
Introduction: The porphyrias are a group of inherited or acquired
disorders caused by deficiencies in the activities of the enzyes of the heme
biosynthetic pathway (Table 1, 1), Therefore, in the porphyrias, the
fundamental defect is in heme synthesis. While inherited porphyrias are due
to a gene defect, their phenotye often remains silent, both biochemically
and clinically, and requires another insult
, either genetic or environmental.
Some of the important endogenous and environmental factors known to
precipitate or exacerbate acute attacks of porphyria are endocrine factors
inadequate nutrtion or exposure to drgs and other foreign chemicals
(Bonkovsky et aI. , 2000), Eight enzyes are involved in the synthesis of
heme and with the exception of ALAS an enzyatic defect at each step of
heme synthesis is associated with a form of porphyria (Table 1, 1),
Classification of porphyria: Porphyrias are traditionally grouped into
hepatic and eryhropoietic porphyrias depending upon the major site of
expression of enzyatic defect, either hepatic or eryhropoietic cells.
Another categorizing scheme is based on the occurrence in some patients of
acute symptomatic attacks interspersed by non-symptomatic latent periods
Table 1.1: Enzyme defects, clinical symptoms, and inheritance of human
porphyria. Classifications of porphyria, the enzyme defects and the
inheritance are listed in the order that the enzes occur in the heme
biosynthetic pathway. Note that photosensitivity is a feature of all of the
porphyrias that are associated with porphyrin accumulation as seen in the
defects associated with enzes that are distal to ALAS , whereas
neurological features occur in those enzyme defects that are proximal to
ALAS, ALAD, ALA dehydratase; PBGD, PBG deaminase; UROD
uroporphyrinogen III decarboxylase; COPRO' GEN, coproporphyrinogen;
PROTO' GEN, protoporphyrinogen; AR, autosomal recessive; and AD
autosomal dominant.
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. 1
and therefore, are classified as chronic or acute porphyrias.
Symptoms of porphyria: Elevated ALAS- l plays a key role in
precipitating the acute porphyrias (Kappas et aI. , 2000). As a result
abnormally elevated levels of porphyrins and/or their precursors , e, g. ALA
and PBG are produced in excess , accumulate in tissues , and are excreted in
urine and stool (Kappas et aI. , 1989 and 2000). Two major symptoms of the
porphyrias are cutaneous photosensitivity and/or neurological disturbances.
Many chemicals that exacerbate porphyria are called porphyrinogenic.
Treatment of Porphyria: Patients suffering from acute hepatic
porphyrias should avoid exposure to porphyrinogenic compounds, because
of the extreme and debilitating symptoms that occur after such exposure
(Kappas et aI. , 2000). Heme infusion and placing the patient on a high
carbohydrate diet, as a method to reduce hepatic ALAS activities , are
treatments that utilize the biochemical knowledge about the regulation of
hepatic heme biosynthesis. Reversion of ALAS activities to normal is
associated with an asymptomatic state (Bonkowsky et aI. , 1971; Pierach
1982; Kappas et aI. , 2000),
Research Objectives
Obiective 1: To determne ifLMH cells. a chick hepatoma cell line. 
are a good model comparable to CELCs. for the study of heme biosynthesis
and regulation of the heme biosynthetic enze. ALAS- In CELCs and
LMH cells , similar patterns of response of ALAS- l activities and mRA
levels were obtained following treatments known to affect heme
biosynthesis. In addition, a synergistic induction of ALAS activity by Glut
and DHA, previously shown in CELCs, was demonstrated in LMH cells.
Similarly, heme-dependent repression of ALAS- I mRA levels for both cell
tyes and of induced-ALAS activities for LMH cells were demonstrated.
These results suggest that LMH cells provide a useful model system for
further studies of regulation of hepatic heme metabolism.
Obiective II: To establish a "glucose effect" on ALAS- I enzye
activity in LMH cells and CELCs in the absence of serum or hormones. and
to determne whether glucose or other metabolizable sugars decrease the
activity of transfected reporter gene constrcts under control of the ALAS-
promoter. The optimal glucose conditions for induction by Glut and DHA
and dose-responses of glucose repression of Glut and DHA and Glut and
FeNTA-mediated induction of ALAS- I enze activity were characterized
in LMH cells and CELCs, Other metabolizable sugars and the non
metabolizable sugars , 2-DOG and sorbitol , were tested for their ability to
alleviate Glut- and DHA-upregulation of a reporter constrct containing
approximately 9, 1 kb of 5' - flanking region of the chick ALAS- l gene in
LMH cells, These results establish that both glucose and other metabolizable
sugars lead to down-regulation of an approximately 9, 1 kb constrct
containing the 5' - flanking and 5' -UTR region of the chick ALAS- l gene,
These effects on enzye activity and promoter constrcts were observed in
the absence of insulin, glucagon, other hormones or serum.
Obiective III: To characterize effects of drgs. and selected chemicals
that inhibit heme synthesis such as. DHA. and heme. on the upstream
regulatory region of the chick ALAS- l gene. Activation of the ALAS-
promoter by the combination of an inducer of ALAS-
, Glut, and an
inhibitor of heme synthesis , DHA, and the effect of exogenous heme on
basal and Glut-and DHA-induced reporter activity was tested in transient
transfection assays. The effects of drgs (induction) and heme (repression)
of ALAS- l were shown to be regulated by separate and distinct regions of
the cALAS- l promoter. Transient and stable transfection assays using
I _
reporter constrcts containing successive deletions of the cALAS-
promoter sequence were used to further delineate (from 5622 bp to 2819 bp)
the 5' - flanking region of the gene involved in mediating heme-dependent
repression of ALAS- I, Drug-responsive enhancer (DRE) sequences
upstream (~- 13 kb) of the -9.1 kb region of ALAS- l gene, that mediate 30-
40-fold up-regulation of ALAS- , were PCR amplified and shown to be
repressed by the early promoter region of ALAS- l (which is not repressed
by heme). Results from these experiments suggest heme can repress ALAS-
1 cis-acting element(s) in the - 3 to - 5 kb 5' -flaning region of the gene
and that although drgs can directly activate the - 5 to +0,082 kb region
the extent of drg induction is dependent upon heme levels in the cell.
CHAPTER II
MATERIALS AND METHODS
Materials
General materials. Levulinic acid was from Aldrich, Milwaukee, WI.
Tissue culture dishes and 6 well (3 cm) plates were from Coming, Coming,
NY; culture flasks were from falcon, VWR Scientific , Bridgeport, NJ.
Methanol and 2 pentanedione (acetyl acetone) were from EM Science
Gibbstown, NJ. Chloroform, glycerol , potassium phosphate, and isopropanol
were from Fisher, Pittsburgh, P A. Fetal bovine serum, geneticin (G418),
LipoFECTAMINE Plus , opti-MEM, trsin, Williams ' E powder and
Waymouth' s MB 752/l1iquid were from Invitrogen Corporation
GIBCO/BRL, Grand Island, NY. 2-Allyl- isopropylacetamide (AlA) was
from Hoffmann-La-Roche, Inc. , Nutley, NJ, Random hexamers (pd(N)6)
and Oligo-dT (12- 18 bases) was from Pharmacia, Piscataway, NJ. Hemin
chloride and porphyrin standards (uroporphyrin, coproporphyrin, and
protoporphyrin) were from Porphyrn Products , Logan, UT. Luciferase
Assay Reagent was from Promega, Madison, WI. Maxi- Midi- and Mini-
prep plasmid DNA isolation and agarose gel extraction kits were from
, n
Qiagen Corporation (Valencia, CA). Adenosine trphosphate (A TP), bovine
serum albumin (BSA), 8-( 4-chlorophenylthio) adenosine monophosphate (8-
CPTcAMP), coenzye A, deferoxamine mesylate (DFO), 2-deoxy a-
glucopyranoside (2-DOG), dexamethasone (Dex), p-dimethylamino
benzaldehyde, dimethylsulfoxide , EDTA, EGTA, ethanol , ferrc chloride
formaldehyde (37% v/v), formamide, frctose, galactose, glacial acetic acid
glutethimide, glycine , glycylglycine, lactate, mercuric chloride , 2-methyl-
di- pyridyl propadone (metyapone), mifepristone (RU-486), NADPH
nitrlotracetic acid 
(NT A), o-nitrophenyl galactopyranoside (ONPG),
penicilin, perchloric acid, phenobarbital (disodium salt), potassium
monophosphate , 5 -pregnene- 3 P-ol- 20-one- 16a-carbonitrle (PCN),
pyridoxal-5' -phosphate , sodium acetate, sodium chloride, sodium dodecyl
sulphate (SDS), sodium hydroxide, sorbitol, streptomycin, succinic
thiokinase (EC 6, 1.4), 3 3' - triodo- thyronine (T3), and Trizma base
were from Sigma (St. Louis, MO), Gelatin was from J. T. Baker
Philipsburg, NJ, Ultraspec RNAzolQY was from Biotecx, Houston, TX.
QuickHybQY was from Stratagene, La Jolla, CA, Nitrocellulose (0.45 
was from Schleicher and Schuell, Keene , NH. All P-radionucleotides were
from New England Nuclear, Boston, MA. Radiolabeled probes were
generated using the DECAprime II DNA Labeling Kit from Ambion
Austin, TX or Ready- To-Go DNA Labeling Beads from Pharmacia Biotech
Piscataway, NJ. All chemicals were of the highest purity available.
Cells and DNA. Fertilized Barred Rock chicken eggs were from Carousel
Farms , Hopkinton, MA. LMH cells and pGAD-28 plasmid were a generous
gift from D. L. Williams , Department of Pharmaceutical Sciences , SUNY-
Stony Brook, Stony Brook, NY, Chick ALAS- l cDNA used as a template
for generating labeled probe was a gift from D. Engel , Northwestern
University, Evanston, IL. The pGcALAS3. Luc and pGcALAS9. Luc
constrcts containing chick ALAS- l promoter sequence were kindly
provided by Dr. Timothy J. Sadlon and Dr. Brian May, Department of
Molecular Biosciences , University of Adelaide, South Australia, Australia.
The pPGK- gal plasmid was a gift from P. Dobner, Department of
Molecular Genetics and Microbiology, University of Massachusetts Medical
School , Worcester, MA. PGKneo plasmid was a kind gift from Dr. Eva Lee
University of California, San Diego, CA. PGL3SV40 constrct, primer RV
primer3 and primerGl2 were purchased from Promega, Madison, WI. -DNA
sequencing was performed by the Nucleic Acids Facility, University of
Massachusetts Medical School, Worcester, MA.
Methods
Cell culture and preparation of chemicals. LMH cells were maintained
in Waymouth' s MB 752/1 complete medium (Appendix A) on 0, 1 % (w/v)
gelatin-coated flasks and passaged routinely 1 to 2 times a week. Cultures of
CELCs were obtained every week and plated in Williams
' E medium
(supplemented with I.5 IlM T3
, and 0, 76 M dexamethasone) as previously
described (Lincoln et aI. , 1988), Complete (containing 10% v/v fetal bovine
serum) and serum-free Williams ' E (Appendix A) and Waymouth' s media
were supplemented with 100 U/mL penicilin and 100 Ilg/mL streptomycin.
CELCs and LMH cells were plated on 6 cm Corning dishes for most
experiments , except for transient transfections of LMH cells
, when cells
were plated on 6 well (3 cm) plates. LMH cells were trsinized
centrifuged, resuspended, and plated at 50-60% confluence in 3 or 5 mL
Waymouth' s complete medium, After 24 h, the cells were washed IX with 2
mL ofWaymouth' s complete medium to remove any unattached cells and
then 3 or 5 mL of the same medium was added. For transfection experiments
with LMH cells , 24 h after plating cells were washed as described above and
transfected with Luc constrcts and pPGKp-gal as described (see
J -
Transfections). For experiments comparing CELCs and LMH cells
, on the
day of treatment, LMH cells and CELCs were washed IX with 2 mL
Williams ' E serum- free medium and S mL of the same was added.
Preparation and treatment with chemicals was exactly as described for
CELCs (Lincoln et aI. , 1988). All chemicals were freshly prepared on the
day of treatment and added directly to culture medium (Appendix B). For
experiments testing the glucose effect on ALAS
, LMH cells and CELCs
were isolated as described above except on the day before treatment the
medium on the cells was changed to Williams
' E medium without serum
, glucose or pyrvate. Twenty-four h later, selected plates received
specified amounts of glucose or other selected metabolizable sugars such as
frctose, galactose, glycerol and lactate or the non-metabolizable sugars -
sorbitol and 2-DOG. After 2 h of exposure to glucose, the cells were treated
with Glut (SO 
IlM) in combination with DHA (2S0 IlM) or FeNTA (SO IlM).
After 16 h of treatment with chemicals, cells were harvested and ALAS-
(enzye or Luc) activity and protein content were determined,
Measurement of ALAS enzye activity. ALAS activity was measured
essentially as described previously (Cable et aI.
, 1991) and as described
below except that the samples were snap-ftozen in liquid nitrogen as whole
cells and stored at - C for 1-2 weeks prior to assay. Initial experiments
showed that ALAS activity was stable under these storage conditions. The
assay measures the rate of conversion of glycine and succinyl-CoA in the
presence of the cofactor PLP to form ALA. The ALA formed is converted
into a pyrole (Figure 2, 1) and reacted with Ehrlich' s reagent p-dimethyl
amino benzaldehyde (2% DMAB) to form a colored Ehrlich' s pyrole salt
(Figure 2, 1). The activity of ALAS is determned from the concentration of
this product obtained by measuring OD 555-650 nm (Mauzerall and Granick
1956; Sinclair and Granick, 1977; Lien and Beattie, 1982). LMH cells or
CELCs were plated on 6 cm dishes as described above, After 24 h the cells
were treated with selected chemicals. After 18 h the plates were washed
twice with IX PBS and harvested in 700 ilL of assay buffer (Appendix A)
designed to maintain pH at 7.4 for at least 30 minutes at 37 C. Each cell
suspension was sonicated for 6 seconds using a sonicator (Bronson Model
. 450 , VWR scientific, Bridgeport, NJ) equipped with a microtip (output: 2
duty cycle: 30), Each sonicate (150 Ill) was added to each of three 12 x 75
mm culture tubes , one blan and two assay duplicates. To the "blank" tubes
at time t=O , trichloroacetic acid (TCA) to a final concentration of 4% (w/v),
and 10 III of 1M glycine (pH 7.0), were added after which they were kept on
. -
ice throughout the incubation. Each "blank" tube was used to zero the
corresponding "assay" tubes during spectrophotometr. Glycine (1 M; 10 Ill)
pH 7. , was added to the assay tubes at t=O and incubated at 37 C in a
shaking water bath for 30 minutes after which TCA was added to the tubes
to a final concentration of 4% (w/v). The blank and assay tubes were treated
identically from this point onwards, The samples were centrfuged for 
minutes at 1000 x g and 150 ilL of the supernatant containing ALA was
placed in a separate tube, 100 J.L of 10% (v/v) 2 pentanedione in I.O M
sodium acetate (pH 4,6) was added to the TCA supernatant
, and the mixture
was incubated at 85 C for 15 minutes to form an ALA-
pyrole (2-methyl-
acetyl- propionic acid pyrole) in a Knorr-tye condensation reaction
(Figure 2. 1). The ALA pyrole was converted into a chromophore by the
addition of250 ilL of modified Ehrlich' s reagent (DMAB), 0,375% (w/v)
mercuric chloride in a 4:21 (v/v) solution of70% w/v perchloric acid: glacial
acetic acid), The chromophore has a E555-650nm = 65 mM- l (Lien and
Beattie 1982; Sinclair and Granick
, 1977), The mono Ehrlich' s salt, DMAB
adduct, a chromophoric Ehrlich' s salt forms in solution with a maximum
absorbance after 10 minutes, This timing is important as longer incubation
(? 15 minutes) allows a secondary reaction to form a colorless dipyrole
1" u
Figure 2.1: Mechanisms of the reactions utilized in the assay for ALAS.
Reaction 1: The reaction carred out in vitro and catalyzed by ALAS using
glycine and succinyl CoA with PLP as a cofactor. Reaction 2: The formation
of an ALA pyrole (2-methyl-3-acetyl- propionic acid) (Viale et aI.
1987a). This reaction converts the ALA formed by the enze into an
Ehrlich' s reactive species. Reaction 3: Conversion of the ALA pyrole to a
chromophore, the characteristic red Ehrlich' s ALA salt (Viale et aI. , 1987b),
Solutions of this compound are quantified and the nanomoles of ALA
formed in the in vitro enzye reaction are calculated using the equation
described under Measurement of ALAS- l enzye activity
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phenyl methane (Lien and Beattie, 1982) which can lead to a decrease in
absorbance.
Nanomoles ALA =
OD (555-650) x .75 mL final volume in cuvette x .25 mL final volume
065 OD/nmole ALNmL x path length in cuvette x . 15 mL initial volume
Measurement of porphyrins, Cells and medium from each plate were
harvested together and disrupted by sonicating for 6 seconds with a microtip
sonicator (Branson Heat Systems W225 sonicator, Danbury, CT), From the
time the cells were treated, all steps were carried out in subdued lighting.
Measurement of total porphyrins and ofuro- , copro- , and proto-porphyrin
were carred out using a spectrofluorometrc procedure as previously
described (Grandchamp et aI. , 1980). Briefly, the samples were extracted by
adding 1 mL 5% (v/v) perchloric acid in methanol to 1 mL of sonicate
centrifuged at 1000 X g for 10 minutes and the supernatant aliquotted into
cuvettes for fluorescence measurements. Fluorescence was measured with a
luminescence spectrometer (LS50B , Perkin Elmer, Norwalk, CT) at the
following excitation/emission wavelength pairs: 400/595
, 405/595 , and
410/595 nm. The results were compared with known concentrations (50
/Jg/mL) of uroporphyrin, coproporphyrin, and protoporphyrin as standards,
In previous studies , direct comparisons of the spectrofluorometric and HPLC
methods for detecting porphyrins (Sinclair et aI. , 1986; Bonkovsky et aI.
1987) have shown good agreements (coefficients of variation -: 0%).
Uroporphyrin and heptacarboxyporphyrin on HPLC are detected
spectofluorometricallyas ' uroporphyrin ; hexacarboxy-, pentacarboxy- , and
copro-porphyrins are measured as ' coproporphyrin ; and tri- and
dicarboxyporphyrins as 'protoporphyrin ' (Sinclair et aI. , 1986; Bonkovsky et
aI. , 1987).
Isolation ofRNA. Total RNA was isolated using Ultraspec RNAzoICI
according to the manufactuer s protocol. After removing medium, 0. 5 mL
Ultraspec RNAzolCI was added to the plates and cells from each 6 cm dish
were harvested by scraping with a rubber spatula, Total RNA was isolated as
described (Cable et aI. , 1994), Briefly, the cellular lysates were transferred
into 1,5 mL microfuge tubes , 100 ilL of chloroform added, vortexed, and
incubated on ice for 15 minutes, After 15 minutes, the mixtures were
centrifuged at 14 000 x g and at 4 C for 15 minutes , which causes them to
separate into a heavier, lower, cloudy organic layer and an upper, more
transparent aqueous phase. The aqueous phase was carefully removed with a
T--
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pipette , without touching the interphase, and transferred to a new tube. An
equal volume (300-400 f.L) of cold isopropanol was added, the tubes
vortexed briefly but vigorously and incubated at - C for 1 h. After 1 h, the
tubes were centrfuged (14 000 x g at 4 C for 15 minutes), the supernatants
removed, and the pellets washed with 0,5 mL of75% (v/v) ethanol to
remove any residual isopropanol. The pellets, which contain RNA, were
dried in a Speed- V ac (Savant), and suspended in 50 ilL of DEPC-treated
water for dot blots or 0.5% SDS for northern blots, samples were either
stored at - C or used directly for northern or dot blots. For blotting, the
samples were incubated at 65 C for 45 minutes , and the absorbance ratio at
260 nm /280 nm was determned, Samples with a 260 nm / 280 nm ratio of
8 or higher were considered sufficiently free of contaminating proteins
and the RNA concentrations were estimated from the absorbance at 260 nm
(l AU = 40 Ilg / mL RNA) (Sambrook et aI. , 1989),
Preparation of radiolabeled probes. Radiolabeled probes for detection of
mRA for chicken ALAS- , and chicken glyceraldehyde phosphate
dehydrogenase (GAPDH) were synthesized by random priming and
incorporation of a dCTP using Ready- To- DNA labeling beads
from Pharmacia Biotech (Piscataway, NJ) or the DECAprime II DNA
Labeling Kit from Ambion, Inc. (Austin, TX). The chicken ALAS-
(cALAS- l) probe template was a 1.7 kb EcoR I fragment of the pALX
plasmid containing the cALAS- l cDNA. The GAPDH probe template was a
530 base pair (bp) PCR product obtained using the linearized pGAD-
plasmid as template and the primers GAP 1: 5' GAA AGT CGG AGT CAA
CGGATT TG-3' and GAP2: 5' TGG CAT GGA CAG TGG TCA TAA
GAC- . The PCR program for GAPDH was as follows: delay, 94 C for 3
minutes; 30 cycles of segment 1 , denaturation, (94 C for 1 minute 30
seconds), segment 2 , renatuation (54 C for 2 minutes), segment 3
elongation (72 C for 2 minutes); delay 72 C for 10 minutes; soak at 4
Poly-A probe template was a 12- 18 base polythymdylate oligonucleotide
from Pharmacia Biotech, The Poly-A probe was end-labeled with a
dCTP using T4 polynucleotide kinase and the DECAprime II DNA
Labeling Kit from Ambion Inc. and used as a control for RNA loading,
Quantitation of messenger RNA.
Dot Blots. The dot blotting protocol used total RNA and a probe that had
previously been shown to react with the mRA of interest (Cable et aI.
1991; Cable et aI. , 1994). After RNA isolation, as described in Methods , (see
Isolation ofRNA), total RNA was resuspended in 50 ilL of DE PC treated-
water. Samples were prepared for loading onto the dot blot as follows, for
three blots: 20 ilL of DEPC-treated water, 36 ilL of 20X SSC , and 24 ilL of
37% formaldehyde were added to 40 ilL ofRNA and incubated at C for
15 minutes. For each duplicate blot, 200 ilL of lOX SSC was added to the
samples. The pre-wet (DEPC-water for 5 minutes, rinse with lOX SSC)
nitrocellulose membrane was placed between two sheets of pre-wetted
Whatman 3M paper on the dot blot apparatus. The wells were washed once
with lOX SSC and 200 ilL of RNA was loaded per well in triplicate. The
wells were washed twice with lOX SSC, Duplicate nitrocellulose
membranes were prepared in the same way. The membranes were removed
from the dot-blot apparatus and the RNA cross-linked to the membranes
using a UV Stratalinker (Stratagene, La Jolla, CA). The blots were
prehybridized with QuickHybCI at C for 30 minutes. After
prehybridization, selected radiolabeled probes (see Preparation of
radiolabeled probes) were boiled and added to the QuickHybCI solution at
C for Ihour. After hybridization, the blots were washed with O. IX SSC
at 25 C for 30 minutes with three buffer changes to remove non-specific
binding, The amount of specific mRA was quantitated using a
Phosphorimager (Molecular Dynamics
, Sunnyvale , CA) and Image Quant
software and normalized to total Poly-A mRNA, measured on the duplicate
blot probed with the radiolabeled Poly- T probe or to GAPDH mRA
measured on the duplicate blot probed with the radiolabeled GAPDH probe
as described (see Preparation of radio labeled probes
Plasmid constrction.
pGcALAS3. Luc The constrct containing approximately 9. 1 kb of the 5'
flanking region and 5' UTR of ALAS- l was a kind gift from Dr. Brian K.
May, Department of Molecular Biosciences
, University of Adelaide
Adelaide, Australia and constructed as described below. The 5' flanking
region of chick ALAS- l (cALAS- l) gene was obtained from the A clone
(cALAS- I) (Maguire et aI. , 1986). The early promoter region and 5' UTR of
(cALAS- l) (-299 to +82 bp) was first amplified with Pfu DNA polymerase
(Stratagene, La Jolla, CA) using the primers 5' - AAT GAG AAG CTT TGA
GATTTG TG-3' and 5' CCG CCT CCA AGC TTC CTC CTG-
. The
PCR product was then digested with Hind nI (underlined) and cloned into
the Hind In site of a modified pGL3 Basic plasmid vector (Promega
Madison, WI) in which the Not I site at 4651 bp was destroyed by blunting
with T4 DNA polymerase to make pGcALASO, Luc, To constrct
pGcALAS3, Luc, the vector pGcALASO. 1uc was digested with Sma I
and a Sma I fragment (-3447 to - 165 bp) isolated from A clone cALAS-
was inserted,
pGcALAS9. Luc The constrct containing approximately 9. 1 kb of the 5'
flanking region and 5' UTR of ALAS- l was a kind gift from Dr. Brian K.
May, Department of Molecular Biosciences, University of Adelaide
Adelaide, Australia and constrcted as described below. To constrct
pGcALAS9, Luc , the vector pGcALASO. Luc, was digested with Not I
and Xho I, and an approximately 9. 1 kb Xho I to Not I restriction fragment
isolated from the A clone cALAS- l was inserted. The approximately 9. 1 kb
9067 to +82 bp) fragment represents the parental fragment form from
which all other deletions were generated. Deletion constrcts were produced
by restriction enzye digestion and ligation of the excised region as
described below. Two mg ofpGcALAS9.1-Luc containing approximately
1 kilobases (kb) of genomic chicken 5-aminolevulinate synthase-
(cALAS- l) sequence was digested with Xho I and subsequently 1 mg was
digested with Pml I or Pac 1. The ends were blunted with T4 DNA
polymerase and dNTPs and the restriction fragments separated on a 0.
agarose gel. The fragments of expected sizes were excised from the gel
using a sharp razor blade under UV light and placed in microfuge tubes. The
DNA in the gel pieces was extracted using the QIAquickCI gel extraction kit.
The DNA was quantitated and ligated using T4 DNA ligase
, along with
appropriate no ligase and no DNA controls. The ligation mix was
transformed into DH5a competent cells and plated on Luria Broth agar
plates supplemented with 100 Ilg/mL ampicillin, and incubated overnight at
C. Positive colonies were identified by DNA minipreps and screened for
the deletions by restrction enzye digestion with Sma 1. Colonies that were
positive by restrction digestion were verified by sequencing junctions using
the commercial primer RV primer3 (Promega
, Madison, WI),
Druf! Resvonsive Element (DRE) Constructs of vGcALAS9. Luc,
pGcALASO.3-Luc and vGL3promoter The chick ALAS- l - 13793 to - 13271
bp 5' flanking region containing a 167 bp drg responsive enhancer
sequence (DRE) (Fraser et aI. , 2002) was first amplified using ~ 1 ng of
chickgenomic DNA and primers 5'
- AGT ACA GCT A TG GAT CTG TT-
3' and 5' CCG CCT CCA AGC TTC.CTC CTG- . PCR generated a 522 bp
product which was sequenced and found to contain the DRE and to be
identical to the selected region. A second PCR was performed using gel
extracted PCRI product as template with the same primers but containing
Mlu I sites on the ends 5'
-cga cgc gt AGT ACA GCT ATG GAT CTG TT-
3' and 5' -acg cgt cg GTC TTG ATA GGG CTA ACT TT-3' (Mlu 1 sites in
lower case). The 538 bp PCR2 product was digested with Mlu I and cloned
into the Mlul site (upstream of the Xho I site) (Appendix E) ofcALAS-
promoter-reporter constrcts
, pGcALAS9.1- and O, Luc , and into the
multiple cloning site of a heterologous promoter constrct
, pGL3SV 40-Luc
(Promega Madison, WI). This was done by ligation of Mlu I -digested (and
gel-extracted) PCR2 product with 0. 1 Ilg of fMlu I-digested and calf-
intestinal phosphatase (CiP)-treatedl pGcALAS9. Luc and pGL3SV40-
Luc and pGcALASO. Luc using T4 DNA ligase, with no ligase and no
DNA controls, The ligation mix was transformed into DH5a competent cells
and plated on Luria Broth agar plates supplemented with 100 
Ilg/mL
ampicilin, and incubated overnight at 37 C. Positive colonies were
identified by DNA minipreps and screened for the DRE by restrction
enzye digestion with Mlu 1. Single colonies that were positive by
restriction digestion were verified by sequencing junctions using the
commercial primer RV primer3 (Promega, Madison, WI) and found to be
identical to the selected region.
Transfections.
Transient transfection: LMH cells were plated on 0. 1 % (w/v) gelatin coated
6-well (3 cm) plates at a density of 1.5 x 10 cells/well, After 24 h each well
was transfected with 0.5 Ilg ofpGK-pgal and 0, g of cALAS-
promoter/reporter DNA using LipoFECTAMINE Plus (0.33 Ilg/IlL of
reagent), according to the manufacturer s instrctions, In the DRE
experiments, cells were on 24-well (1.4 cm) plates and the transfections
treatments were performed similarly to that described here. Total DNA
transfected was kept constant by adding pBLUESCRIPT KS II+ plasmid
DNA. Cells were then incubated at 37 , 5% CO for 3 h, after which 2 mL
ofWaymouth' s complete medium was added and incubated overnight.
Twenty-four h after transfection, cells were washed and plated with
Waymouth' s medium containing penicillin-streptomycin but no serum and
treated with selected chemicals.
Stable transfection: LMH cells were stably transfected essentially as
described above with 0,3 Ilg ofpGKNeo and I.5 Ilg ofcALAS-
promoter/reporter DNA. Twenty-four h after transfection, each well of
transfected cells was trsinized and transferred onto 4 to 6 , 10 cm plates in
Waymouth' s complete medium (with serum but without G418), The cells
were allowed to recover overnight and in the morning the medium was
changed to Waymouth' s complete medium supplemented with 250 Ilg/mL
G418, The cells were maintained in G418 medium for 3-4 weeks until most
of the cells died, Cells transfected with the neomycin resistance gene
survived as single cells, which then grew into single colonies in 3-4 weeks,
Such colonies were isolated using trsin and transferred into gelatin coated
48-well plates and subsequently, after reaching confluence
, into 24-well (1.4
cm), 12-well (2.12 cm), and 6-well (3 cm) plates containing Waymouth'
complete medium with 250 Ilg/mL G418. Putative stably-transfected
colonies were identified by testing their luciferase activity, Eight-ten
independent single colonies were isolated and tested for each constrct and
only colonies containing basalluciferase activity and inductive/repressive
responses after treatment with chemicals similar to transiently transfected
cells were used in further studies described.
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Assessment of reporter gene activity, Reporter gene expression was assessed
by quantitation of luciferase activity, normalized to galactosidase ( gal)
activity, and protein content in the case of transient transfection experiments
or just protein content in the case of stable transfection experiments. For
luciferase activities , transfected cells were washed 2 times with IX PBS
, and
harvested in 250 L of glycylglycine harvest buffer (Appendix A), Cells
were lysed by freeze-thaw (3 cycles of 3 minutes in liquid nitrogen and 3
minutes at 37 C). The cellular fragments were centrifuged for 10- 15 min at
000 X g in the cold. The supernatant (15 ilL each) was assayed for
luciferase and gal activities and protein content. For luciferase activity
measurements, luminometer tubes were placed into a Monolight 201 
OCI
Luminometer (Analytical Luminescence Labs
, An Arbor, MI) and 100 ilL
of Luciferase Assay Reagent (Promega
, Madison, WI) was automatically
injected, Relative light units (RLU) produced in 10 seconds were recorded
and normalized with gal activities (for transient transfections) and protein
content. gal activities were measured by a colorimetric assay (Sambrook et
aI. , 1989), The cell lysate (15 L) was added to 200 L ofZ-buffer
(Appendix A) and 100 ilL of 5 mg/mL ONPG dissolved in 0. 1 M potassium
phosphate, pH 7. , and incubated at 37 C for 30-60 minutes. The
absorbance at 420 nm was measured as a measure of p-gal activity which
was used normalization of luciferase activity.
Measurement of protein concentrations
. The amount of protein in the sample
was measured by the bicinchoninic acid method (BCA) on a GENESYS 2
(Thermo Spectronic, Rochester, NY) or Synergy HT spectrophotometers
(BIO- TEK Instrments INC" Winooski , VT) using BSA as standard (Smith
et aI. , 1985). A protein standard curve was generated in each experiment and
used to determne the protein content of each sample.
Statistical analysis of data. In all experiments, each condition included at
least triplicate samples. All experiments were repeated two to six times with
consistent results. Statistical analyses were performed using JMP 3,
software (SAS Institute, Cary, NC). Initial descriptive statistics showed that
the results for continuous variables were distrbuted normally. Therefore, the
differences in mean values were assessed by ANOV A
, with the Tukey-
Kramer correction for multiple pair-wise comparisons, P values -:0, 05 were
considered significant.
CHAPTER III
CHARACTERIZA TION OF HEME BIOSYNTHETIC 
P A THW A Y 
THE CHICKEN HEPATOMA CELL LINE, LMH AND CHICK
EMBRYO LIVER CELLS (CELCS)*
Introduction
The purpose of the studies in this Chapter was to characterize the
heme biosynthetic pathway and regulation of ALAS- l (the rate-controllng
enzye for heme biosynthesis) in a continuous cell culture model, LMH, in
comparison with chick embryo liver cells (CELCs). The inducibility and
regulation of ALAS- l have been investigated using a variety of models
including intact animals (Bonkowsky et aI. , 1973; Bonkowsky et aI. , 1978)
and primary liver cell cultues (Cable et aI. , 1991; Russo et aI. , 1994). Chick
embryo liver cell culture yields data similar to that observed in whole
animals such as chick embryos (Ades and Stevens 1988; Hamilton et aI.
1988), mice (Smith et aI. , 1989), rats (Marks et aI. , 1987) or man (Kappas et
aI. , 1989; Bonkovsky et aI. , 1990). Thus , CELC are a widely used culture
model that closely approximates what occurs in vivo and in humans (Healey
et aI. , 1981; Bonkovsky et aI. , 1985), Unlike rat hepatocytes (Bissel et aI.
1980) CELCs, simply cultured on plastic dishes without special coatings or
supplements to standard cultue media, retain normal levels and inducibility
of ALAS- l mRA and activity (Cable et aI. , 1991; Russo et aI. , 1994), Cyp
(Hamilton et aI. , 1988) and HO- l (Cable et aI. , 1991), Therefore, CELCs are
a powerful and convenient system for the study of heme metabolism 
in vitro.
However, there are some limitations to the primary culture system: the cells
obtained are somewhat heterogeneous; the isolation must be repeated every
week, resulting in culture-to-culture variations and practical limitations on
the number of cultue dishes that can be employed in any given experiment.
Even then, they are short-lived and eventually become overgrown by
fibroblasts (0. Gildemeister, Unpublished observations), limiting the
feasibility of time-course and transfection studies.
LMH cells are a chicken hepatoma cell line derived from a liver
hepatocellular carcinoma induced by giving intra-peritoneal injections of
diethyl nitrosamine to a male White Leghorn chicken (Kawaguchi et aI.
1987). LMH cells, an immortal cell line, have several advantages over
CELCs; continuous long-term culture, cell-tye homogeneity, and a virtually
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endless supply. In LMH cells , the induction of HO- l in response to
treatments such as heme, transition metals, sodium arsenite , and heat shock
was similar to that seen in CELCs (Gabis et aI. , 1996), It was also shown
recently that LMH cells respond to a variety of drgs by induction of
CYP2Hl , a major drug-metabolizing enzye in chick liver (Hands chin et
aI. , 2000).
The research presented in this Chapter characterizes the heme
biosynthetic pathway and regulation of ALAS- l in LMH cells and compares
these results to those in CELCs, The purpose of these studies was to
determne if LMH cells are as good a model as CELCs for studies of heme
biosynthesis and regulation of ALAS-
Results
Comparative effects of selected chemicals that affect heme synthesis on
ALAS activity in CELCs and LMH cells. It has been shown previously in
CELCs that treatment with selected combinations of chemicals increases
ALAS- l activity and that elevated activity is maintained from 12 to 24 h
after treatment (Hamilton et aI. , 1988; Lincoln et aI. , 1988; Cable et aI.
1991; Russo et aI. , 1994). Hence, in this study, ALAS activity was measured
in both CELCs and LMH cells after 18 h of exposure of cells to treatments.
All of the selected treatments increased ALAS activity to varying degrees
(Figures 3. 1 A and B). Phenobarbital (PB) and glutethimide (Glut), either
alone or in combination with 4 dioxoheptanoic acid (DHA) or
deferoxamine (DFO), increased ALAS activity several fold over control.
Among the combinations tested, the combination of Glut and DHA was
more effective (P-:0.001) at increasing ALAS activity than the combinations
of Glut and ferrc nitrlotriacetate (FeNTA) or PB and DFO in both CELCs
. and LMH cells (Figures 3. 1 A and B),
It was found in CELCs that, by making several modifications in the
assay itself (freeze-thaw to facilitate cellular lysis) and by treating them with
Figure 3.1. Comparative effects of selected chemicals that affect heme
biosynthesis on ALAS enzyme activity in CELCs (A) and LMH cells (B).
CELCs and LMH cells were treated with chemicals and maintained at 370
for 18 h, after which cells were harvested
, sonicates prepared and used to
measure ALAS enzye activity as described in Chapter II. Concentrations
of the selected chemicals were as follows: Glutethimide (Glut) - 50 
IlM;
ferric nitrlotriacetate (FeNT 
A) - 50 
11M; 6 dioxoheptanoic acid (DHA) -
250 11M; phenobarbital (PB) - 800 
IlM; and deferoxamine (DFO) - 250 IlM
in CELCs and 500 IlM in LMH cells
, respectively. As shown in Figures 3.2
and 3. 250 11M DHA alone had no significant effect on ALAS activity in
CELCs and LMH cells. Data represent means + SE from 3-5 independent
experiments in trplicate, *Significant increase vs. none
, Glut alone p-CO.OOI.
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the selected chemicals 24-36 h (rather than 36-48 h) after isolation, we were
able to achieve even higher ALAS activity after Glut and DHA treatment
(Figure 3. 1 A) than those previously achieved (Russo et aI.
, 1994). Hence in
further experiments these procedures for treatment and cell lysis were
routinely used.
Effect of increasing concentrations of DHA on ALAS activity in CELCs or
LMH cells either untreated or treated with Glut: The combination of Glut
(50 IlM) and DHA (0- 500 IlM) synergistically increased ALAS activity in
both CELCs and LMH cells compared with the effect of either Glut or DHA
alone (Figure 3.2). The DHA concentration that gave maximal increase in
ALAS activity in combination with Glut (50 
IlM) was 250 IJM, Hence in
further experiments these were the concentrations of Glut (50 IJM) and DHA
(250 IlM) used.
Effect of selected chemicals on level of ALAS- l mRA in CELCs and
LMH cells. With the exception of FeNTA alone in CELCs
, each of the
selected chemicals increased the levels of ALAS- l mRA (Figure 3.3). The
fold increases in ALAS- l mRA after 6 h of exposure to the combinations
tested, were not as large as those obtained for ALAS activities after 18 h
Figure 3.2. Effect of increasing concentrations of DHA on ALAS
enzyme activity in CELCs (A) or LMH cells (B) left untreated or treated
with glutethimide. CELCs and LMH cells were either left untreated or
treated with increasing concentrations ofDHA (0
, 125 , 250 , 375 or 500 IlM)
and/or Glut (0 or 50 /-M) for 18 h prior to harvest. Cells were then
harvested, sonicates prepared and used to measure ALAS activity as
described in Chapter II, Data represent means + SE from 3-5 independent
experiments in trplicate. *Significant increase vs, none, Glut alone, or DHA
alone P.cO.OOl. The EC was calculated to be 106. 61l Glut for A (R
990), and 143.512 IlM Glut for B (R = 0.982) by Non-linear Regression
analysis using the Hil , 4 Parameter method.
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Figure 3.3. Effect of selected chemicals on expression of ALAS-1 mRNA
in CELCs and LMH cells. CELCs and LMH cells were treated with
chemicals that affect heme biosynthesis for 6 h prior to harvest. Total RNA
was isolated and specific mRAs detected by dot blots as described in
Chapter II. Chemical concentrations were as indicated in legend to Figure
1. The amount of ALAS- l mRA was normalized to GAPDH mRA
which was shown previously to remain constant under the conditions (Cable
et aI. , 1994). Results are. mean + SE from 3-5 independent experiments done
in triplicate. * Significant increase vs. none P-:O.OO1. 9 Significant increase
vs. none P-:0.05.
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of treatment with the same combinations (Figures 3.1 A and B), In contrast
to that seen for enzye activities , effects of Glut in combination with
FeNTA or DHA on ALAS- l mRA levels were not significantly different
from the effects of Glut alone, This is in keeping with previous studies
(Hamilton et aI. , 1988; Russo et aI. 1994) which showed that the synergistic
induction of ALAS- l requires prolonged treatment (12- 18 h) with the
inducers (Glut and DHA) (Russo et aI. , 1994 ).
Porphyrin accumulation in CELCs and LMH cells in response to selected
chemicals that affect heme synthesis, Barbiturates like PB and barbiturate-
like compounds, such as Glut, increase the levels of ALAS- l mRA 
CELCs (Hamilton et aI. , 1988; Jover et aI. , 1996) (Figure 3,3). The effect of
these chemicals alone or in combination with DFO and FeNTA on porphyrin
accumulation was tested in LMH cells and CELCs. As previously described
(Bonkovsky 1989), Glut or PB alone led to accumulation of porphyrins in
CELCs (Figure 3.4 A), indicating that the uninhibited pathway is able to
convert most of the intermediates 
- ALA, PBG, and the porphyrinogens
into heme (Figure 1. 1), PB or Glut in combination with DFO which inhibits
normal heme biosynthesis by chelating iron (Figure 1. 1), resulted in an
accumulation of porphyrins , a major proportion (~1/2) of which was
I u
-, -
Figure 3.4. Porphyrin accumulation in CELCs (A) or LMH cells (B) in
response to selected chemicals that affect heme biosynthesis. CELCs and
LMH cells were treated with the different chemicals for 18 h prior to
harvest. Cells were harvested, sonicates prepared, porphyrins extracted using
PCA:MeOH and assayed by the method of Grandchamp et aI.
, as described
in Chapter II. The concentrations of the chemicals used were as described in
Figure 3. , except the concentration of ALA was 35/-M. Data are presented
as nanogram (ng) porphyrin / mg protein. Data represent means + SE from
5 independent experiments done in triplicate, 9 Significant increase in
protoporphyrin VS. none Po:O,OOI. tSignificant increase in total porphyrin vs.
none PO:O, OOI. Significant increase in uroporphyrin VS. none PO:O.OOI.
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protoporphyrin (Figures 3.4 A and B). ALA alone at 35 
IlM markedly
increased porphyrin accumulation in primary CELCs (Figure 3.4 A), but had
relatively little effect in LMH cells (Figure 3.4 B). In contrast
, DFO alone
did not have much effect in CELCs but the combination of ALA or an
inducer of ALAS- I such as, Glut or PB , with DFO, led to significant
accumulations of protoporphyrin (Figure 3.4 A). Glut or PB alone produced
an increase in porphyrin accumulation that was greater in LMH cells than in
CELCs (Figures 3.4 A and B). When DFO was added in combination with
Glut or PB , a further increase in total porphyrin
, mainly protoporphyrin, was
observed in LMH cells as in CELCs (Figures 3.4 A and B), In preliminary
dose-response studies, we found that 250 IlM DFO was sufficient to produce
near maximal effect in CELCs
, while LMH cells required DFO at 500 IlM to
produce the same effect. Thus
, these concentrations of DFO were used.
ALA dose-res onse, In order to determne why 35 !JM ALA did not lead to
accumulations of porphyrins in LMH cells to the same extent as did in
CELCs, a broader range of concentrations of ALA (0-
500 IlM) were studied.
We found that porphyrins in LMH cells increased with increasing ALA
concentration, reaching a maximal response at 350 IlM (Figure 3.5 B),
J=:
',11
, ,
Figure 3.5. Effect of increasing concentrations of ALA on porphyrin
accumulation in CELCs (A) or LMH cells (B). CELCs and LMH cells
were either left untreated or treated with increasing concentrations of 8-
aminolevulinic acid (ALA; 0
, 35 , 50, 100, 150 200 250 , 300 , 350 400 450
or 500 
IlM) for 18 h prior to harvest. Cells were harvested, sonicates
prepared, and porphyrins extracted using PCA:MeOH and assayed by the
method of Grandchamp et aI.
, as described in Chapter II, Data are presented
as ng porphyrin/mg protein. Data represent means SE from 3-
experiments in trplicate. The EC was calculated to be 24.9 IlM ALA for A
= 0.985), and 93.6 IlM ALA for B (R = 0,992) by Non-linear
Regression analysis using the Hil
, 4 Parameter method.
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whereas CELCs showed increased porphyrin accumulation with increasing
concentrations of ALA up to a concentration of 100 IlM after which a
plateau was reached (Figure 3. 5 A),
Effect of heme on basal ALAS- l mRA. Since heme-dependent
repression of ALAS- l is a major component of the normal regulation of
heme biosynthesis in CELCs (Cable et aI.
, 1991; Russo et aI. , 1994), we
tested if heme repression of ALAS- l mRA occurs in LMH cells as well. In
the presence of heme (20 IlM 6 hour exposure), the uninduced ALAS-
mRA was decreased in both CELCs (28% of control
, P OO 1 ) and LMH
cells (64% of control , P OOI) (Figure 3. 6),
Effect of heme on induced-ALAS activity, In LMH cells the ALAS activity
that had been increased by pretreatment with Glut and DHA or FeNT A for
12 h was decreased (to 68% of control, P Ol and to 55% of control P
respectively) after exposure to 20 IlM heme for 6 h (Figure 3.7).
. C
- " .
Figure 3. 6. Effect of heme on basal ALAS- 1 mRNA. Cultures ofCELCs
and LMH cells were either left untreated or treated with 20 IlM heme for 6 h
and total RNA was harvested, Harvest, isolation, detection and quantitation
of RNA were performed as described in Chapter II, Data represent means +
SE from 3- 5 experiments in triplicate. Significant decrease from all others
O 1. ** Significantly different from untreated LMH cells , and from
heme-treated CELCs P OI.
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Figure 3.7. Effect of heme on induced-ALAS activity. LMH cells were
maintained at 37 oC for 12 h under the following inducing conditions:
untreated, glutethimide (Glut, 50 j.M) alone or in combination with either
ferric nitrlotriacetic acid (FeNTA, 50 IlM) or 4 dioxoheptanoic acid
(DHA, 250 j.M). LMH cells were then treated with 20 j.M heme for 6 h,
The cells were harvested, sonicated, and assayed as described in Chapter II.
Data represent means + SE from 3-5 experiments in triplicate. *Significant
increase VS. Glut alone , DHA alone P-:O,OOI. t Significantly different from
treatment without heme (P-:O. Ol). Significantly different from treatment
without heme (P-:0.05).
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Conclusions
The utility ofLMH cells as a model system for the study of hepatic
heme biosynthesis and regulation of ALAS- l has been demonstrated. LMH
cells exhibited similar responses to CELCs with respect to induction of
ALAS- l mRA and enzyme activity in response to selected chemicals that
affect heme biosynthesis. The absolute levels of ALAS- l mRA and
activity were similar in LMH cells and CELCs, Porphyrin accumulation and
overproduction were seen in response to treatment with chemicals that are
routinely used in models of porphyria. LMH cells displayed a synergistic
induction of ALAS activities in response to Glut and DHA. Synergistic
effects of the combination of Glut and DHA to increase ALAS activity
might be explained by their effects on heme biosynthesis
, by a direct effect
of these chemicals on expression of ALAS gene or by a combination of
both, Thus, LMH cells provide a useful system for further investigation of
the mechanism by which this occurs.
Heme-dependent regulation of ALAS- l mRA levels was seen for
both CELCs and LMH cells in the absence of any inducers. In addition
, as
previously shown by Russo et aI. , 1994, in CELCs , heme decreased the Glut
and DHA-induced ALAS- l activity in LMH cells,
The major difference between primary CELCs and LMH cells was in
"" -
the amount (ng) of porphyrins accumulated in response to the inducers of
ALAS- l and ALA, LMH cells needed higher concentrations of ALA, than
CELCs , to accumulate the same amount of porphyrin, Different sensitivity
to ALA may be due to less avid and/or less rapid uptake of ALA into LMH
cells than into CELCs. Requirements for higher concentrations of ALA have
been well described in a human hepatoma cell line (HepG2) (Iwasa et aI.
1989), in rat hepatocytes (Sinclair et aI. , 1990) and in embryonic stem cells
(Harigae et aI. , 1998). Whether these differences may also be due to
differences in growth rate and metabolism of the given cell tyes is not
known, LMH cells are a rapidly growing tumor-derived cell line with a
doubling time of approximately 21 h, whereas CELCs under our conditions
of culture are essentially non-proliferating and eventually are overgrown by
fibroblasts (0 Gildemeister, unpublished observations).
Drugs such as PB and Glut increased ALAS- l mRA levels and
activities particularly Glut in combination with the inhibitor of heme
synthesis, DHA, synergistically increased ALAS activity in LMH cells as in
CELCs. Heme (20 1l) decreased the Glut and DHA-induced ALAS
enzyme activity and mRA levels in LMH cells as shown previously in
-,--
CELCs (Hamilton et aI. , 1988; Russo et aI. , 1994).
Previous studies in intact rats and CELCs examining the drug
induction of ALAS- l gene expression have been conflicting about the effect
of "the regulatory heme pool" on ALAS- l gene expression vs. mRA
stability (Hamilton et aI. , 1988; Srivastava et aI. , 1988; Srivastava et aI.
1990), Since LMH cells show characteristics that are very similar to primary
CELCs , they provide a useful model system for further studies of the
regulation of hepatic ALAS- 1 expression by drgs, heme and glucose.
CHAPTER IV
EFFECT OF GLUCOSE AND OTHER METABOLIZABLE SUGARS
ON ALAS-1 IN LMH CELLS
Introduction
The chick hepatoma cell line, LMH, and CELCs were used to
characterize the effects of glucose and/or its metabolites on the drg
induction of ALAS- I, In Chapter In it was demonstrated that LMH cells
display normal induction of ALAS- , accumulation of porphyrins in
response to chemicals, and show heme-dependent repression of ALAS-
mRA and activity (Kolluri et aI. , 1999). In addition, treatment ofLMH
cells with DHA in combination with the drg, Glut, resulted in a synergistic
increase in ALAS- l activity. Therefore, LMH cell cultures yield data (Gabis
et aI. , 1996; Kolluri et aI. , 1999; Fraser et aI. , 2002; Fraser et aI. , 2003)
similar to that observed in CELCs (Bonkovsky et aI.
, 1992; Russo et aI.
1994; Jover et aI. , 1996; Hahn et aI. , 1997) and are therefore a simple
reproducible system for exploring hepatic heme and porphyrin metabolism.
The ' inducible ' hepatic porphyrias - acute intermttent porphyria
hereditary coproporphyria and variegate porphyria- are disorders of hepatic
J -
heme biosynthesis caused by inherited partial deficiencies of three specific
enzymes of this pathway. They are collectively called "inducible" hepatic
porphyrias because "acute" attacks are often precipitated by drgs and are
associated with considerable increase in activity of ALAS- l (Granick and
Urata, 1963; Tschudy et aI. , 1965; Perlroth et aI. , 1968; Hahn and
Bonkovsky, 1998) with enhanced hepatic synthesis and excretion of heme
precursors such as ALA, PBG and porphyrins,
It has been known for a long time that administration of large amounts
of glucose to patients with hepatic porphyrias induced by drugs can produce
significant clinical improvement of human acute intermttent porphyria
(WeIland et aI. , 1964) and variegate porphyra (Perlroth et aI. , 1968), and
that dietary and hormonal factors play an important role in the drg
precipitation ofporphyric attacks (For recent reviews see Bonkovsky 2000;
Sassa et aI. , 2002).
Most of the earlier studies investigating the "glucose effect" on heme
synthesis were done on intact animals that were administered
porphyrinogenic compounds (Bonkovsky et aI.
, 1973; DeLoskey and
Beattie, 1984). One difficulty with defining the events responsible for the
glucose effect in intact animals is separating those events attributable
directly to glucose and those events resulting from changes in hormonal
balance within the animal. Cells in culture therefore, are useful for
deciphering the contrbutions that specific nutrents vs. hormones make to
overall regulation of gene expression.
In 1981 , Giger and Meyer showed in CELCs, as had been previously
demonstrated in intact animals (Bonkovsky et aI. , 1973), that frctose
glycerol , and lactate , mimicked the repressive effect of glucose on ALAS
activity (Giger and Meyer, 1981), However, CELCs in this study were
isolated in Williams ' E medium containing 1, 5 IlM T3 and this hormone was
present in the medium throughout the experiments on the glucose effect.
Hence, a possible effect of T3 could not be excluded in the work of Giger
and Meyer.
Given that these earlier studies assessed the effects of glucose on
ALAS enzyatic activities it is also not known whether the effects of
glucose and/or its metabolite(s) on ALAS- l are mediated at the level of gene
transcription. To begin to address some of these unanswered questions
I took advantage of the fact that LMH cells proved to be a good model for
the study of chemically induced experimental porphyria (Chapter III). I
performed preliminary experiments firstly to establish a "glucose effect" on
.' 
ALAS- in vitro in LMH cells, in the absence of any factors such as serum
and hormones , and secondly to determne whether the effects of glucose
and/or its metabolite (s) on ALAS- I are mediated at the level of gene
transcription,
Summary of the "glucose effect" Despite extensive studies of
chemically-induced experimental porphyria in animals and in cell cultures
, it
is not known whether the effect(s) of glucose and/or its metabolite(s) on
ALAS- l occur in the absence of hormones and at the level of gene
transcription, In addition, the molecular mechanism(s) by which glucose
and/or its metabolites regulate ALAS- I have not been elucidated. Such data
may be relevant to understanding of ALAS- l gene regulation by glucose in
patients with ' inducible ' hepatic porphyrias.
Results
Induction of ALAS activity by selected chemicals under different
glucose concentrations in LMH cells. We first wanted to determine the
optimum glucose concentration for induction by Glut and DHA. For this
purpose, cells grown in glucose- and serum-free Williams ' E for 24 h were
incubated with Williams ' E medium containing glucose (mM) as indicated
for 2 h, and then treated with 50 IlM Glut and 250 M DHA, After 16 h of
treatment with Glut and DHA, cells were harvested and ALAS activity
measured as described in Chapter II. Cells in Williams ' E medium
containing 2.75 mM glucose did not induce ALAS activity and cells in 5.
mM glucose induced ALAS activity to a lesser extent in response to Glut
and DHA, than those in Williams ' E containing 8, 25 - 19.25 mM glucose
which gave optimal fold induction over control (4.5 fold) (Figure 4. 1), Cells
in 22 mM glucose had lower Glut and DHA-induced of ALAS- l activity as
compared to cells in 8- 19 mM glucose (Figure 4. 1).
Effect of increasin concentration of lucose on Glut- and DHA-
induction of ALAS activi ty in LMH cells, Since cells in 5. 19.25 mM
glucose increased ALAS activity several fold over control , 5- 11 mM
Figure 4.1. Dose response curve of the amount of glucose required for
. the optimal induction of ALAS activity by Glut and DHA in LMH cells.
LMH cells grown in glucose and serum-free Williams ' E medium for 24 h
were changed to Williams ' E medium containing 0 , 11
13. , 16, , 19.25 or 22 mM glucose for 2 h, and then treated with 50 J.M
Glut and 250 J.M DHA. Cells were treated with selected chemicals for 16 h
after which cells were harvested, sonicates prepared and used to measure
ALAS activity as described in Chapter II. Concentrations of the chemicals
were as follows: Glut, 50 IlM and DHA, 250 IlM. Data are presented as
nanomoles ALA formed/mg protein-hr, Data represent means + SE from 3-
independent experiments in triplicate, Basal ALAS activity in William s E
medium without glucose for untreated samples was 6,32 + 0.07 nanomoles
ALA formed/mg protein-hr.
...... -
rJ -
I..Glut (50JiM) + DHA (250JiM) 
o 2.75 5.5 8. 11 13.7 16.5 19.
Glucose (mM)
1 -
glucose was used as a standard glucose concentration for induction of ALAS
activity in LMH cells. Since regular Waymouth' s medium contains 11 mM
glucose and regular Williams ' E medium 5. 5 mM glucose (Appendix A),
further experiments testing the "glucose effect" on ALAS- l were performed
on LMH cells in regular Waymouth' s medium, The ability of higher
concentrations of glucose (:: 11 mM) to decrease Glut- and DHA-induced
ALAS activity was tested by addition of 11-55 mM glucose to Waymouth'
medium to give effective glucose concentrations of 22 , 33 , 44, 55 and 66
, respectively. Glucose concentrations of 22-66 mM produced a dose-
dependent decrease in the induction obtained by Glut and DHA, compared
to that obtained by Glut and DHA in the presence of 11 mM glucose (Figure
2). The basal ALAS activity in regular Waymouth' s medium for untreated
samples was 1,2 + 0.017 nmoles ALA formed/mg prot-hr (Figure 4,2) and
was 19% lower than that obtained in Williams ' E special medium
(6, 32+0.07 nmoles ALA formed/mg prot-hr) without glucose or sodium
pyrvate (Figure 4. 1).
Effect of increasing concentrations of sorbitol on Glut- and DHA-induction
of ALAS activity, Sorbitol is a non-metabolizable monosaccharide whose
molecular weight is very close to that of glucose (182.2 vs. 180,2 for
,,,
Figure 4.2. Dose response curve of the effect of glucose on the Glut- and
DHA-mediated induction of ALAS activity in LMH cells. Effect of
increasing concentrations of glucose on ALAS activity in LMH cells treated
with 50 IlM Glut and 250 /-M DHA in regular Waymouth' s medium
containing 11 mM glucose. LMH cells were then treated with increasing
concentrations of glucose (11 , 22 , 33 , 44, or 55 mM) to give effective
glucose concentrations of22 , 33 , 44, 55 and 66 mM respectively for 2 h
before treatment with 50 IlM Glut and 250 IlM DHA for 16 h prior to
harvest. Cells were then harvested, sonicates prepared and used to measure
ALAS activity as described in Chapter II. Data are presented as nanomoles
ALA formed/mg protein-hr, Data are expressed as means + SE from 3-
independent experiments in triplicate, Basal ALAS activity in Waymouth'
medium for untreated samples was 1.252 + 0.017 nanomoles ALA
formed/mg protein-hr. *Significantly increase from treatment with Glucose
alone or Glucose (33-66 mM) in the presence of Glut and DHA
, (P':O. O 1),
The IC was calculated to be 29 IlM Glucose by Non-linear Regression
analysis (R = 0.986) using the Hill , 4 Parameter method.
...
--Glut + DBA + Glucose (mM)
-0 Glucose
Glucose (mM)
glucose). Sorbitol is taken up easily by liver cells though to a lesser extent
than glucose. LMH cells in Waymouth' s medium without serum, were either
left untreated or treated with 50 IlM Glut and 250 J-M DHA in the presence
of selected amounts of glucose or sorbitol. Sorbitol (11 , 33 , or 66 mM) did
not decrease the induction of ALAS obtained by Glut and DHA, which was
similar to that obtained in 11 mM Glucose (regular Waymouth' s medium)
(Figure 4.3). Glucose (66 mM), however, did decrease this induction and
served as a positive control for the glucose effect (Figure 4.3). From this
experiment, it was concluded that the effect of glucose on ALAS activity is
specific for glucose and is not due to an increase in tonicity (solute content)
of the medium due to addition of large amounts of sugar.
Effect of glucose on Glut- and FeNTA-induced ALAS activity. The next
experiment tested whether the effect of glucose to alleviate the Glut and
DHA-induction was also tre for induction by other chemical combinations.
Glut and FeNTA (Fe) have been shown to induce ALAS- l by inducing the
normal mechanism for heme degradation via HO- l (see Chapter I
Chemicals that induce ALAS- l by heme degradation) (Cable et aI. , 1990;
Cable et aI. , 1991). Treatment with Glut and Fe did not induce ALAS
in special Williams ' E without glucose as observed for by Glut and DHA
i- 
Figure 4.3. Effect of increasing concentrations of sorbitol on Glut- and
DHA-mediated induction of ALAS activity in LMH 
cells. LMH cells
were grown in regular Waymouth' s medium, treated with selected
carbohydrates and chemicals that affect heme biosynthesis
, and assayed for
ALAS activity as described in Chapter II, Glut and DHA concentrations
were as indicated in legend to Figure 4. 1, Data are presented as nanomoles
ALA formed/mg protein-hr. Results are means + SE from 3-5 experiments
in triplicate, **Significant decrease from treatment with Glut and DHA in
the presence of Sorbitol (11 , 33 , or 66 mM) or Glucose (11 mM) (P-cO.OOl).
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(Figure 4.4 vs. Figure 4. 1). However, Glut and Fe in the presence of 11 mM
glucose induced ALAS 6- fold and higher glucose concentrations (22 and 33
mM) gave inductions of 3 and I-fold respectively thereby decreasing the
Glut- and Fe-induction of ALAS in a dose-dependent manner (Figure 4.4).
Effect of glucose on Glut- and DHA- induced ALAS activity in CELCs.
CELCs were isolated and maintained in regular Williams
' E medium and
changed to Williams ' E medium without glucose or pyrvate or T3 , 24 h
before treatment. Cells were then incubated for 2 h with 0
, 11 or 33 mM
glucose before treating with 50 IlM Glut and 250 IlM DHA or vehicle alone
for 16 h. Treatment with Glut and DHA induced ALAS activity several fold
over controls at 0 and 11 mM glucose, but glucose at 33 mM decreased this
induction in CELCs (Figure 4,5) as seen before for LMH cells (Figure 4,2),
Effect of lucose on Glut- and DHA-mediated induction of GcALAS9.
Luc in LMH cells. To determne whether the effect of glucose on ALAS-
l is
mediated at the level of transcription, Glut and DHA induction and the effect
of glucose were tested on, pGcALAS9. Luc, a constrct containing ~ 9.1
kb of 5' - flanking region of chick ALAS- l gene attached to a luciferase
(reporter) gene. PGcALAS9, Luc was transiently transfected into
Figure 4.4. Effect of glucose on Glut and Fe-mediated induction of
ALAS in LMH cells. LMH cells in glucose- and pyrvate-free Williams ' E
for 24 h were changed to Williams ' E medium containing 0 , 11 , or 33
mM glucose for 2 h, and then treated with Glut and FeNTA (Fe) for 16 
Cells were harvested, sonicates prepared, and assayed for ALAS activity as
described in Chapter II. The concentrations of the chemicals used were Glut
50 IlM and Fe , 50 f.M. Data are presented as nanomoles ALA formed/mg
protein-hr. Data are expressed as means + SE of 3-5 independent
experiments in trplicate, * Significant increase from all others (P-:O. O 1).
**Significant decrease from treatment with Glut and Fe, in the presence of
11 mM Glucose (P-:O.Ol),
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... -- 
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Figure 4.5. Effect of glucose on Glut- and DHA-mediated induction of
ALAS activity in CELCs. CELCs were isolated and maintained in regular
Williams ' E medium and changed to Williams ' E medium without glucose
or pyrvate or T3 , 24 h before treatment. Cells were then incubated for 2 h
with 0 , 11 or 33 mM glucose before treating with 50 IlM Glut and 250 IlM
DHA or DMSO alone for 16 h. Data are presented as nanomoles ALA
formed/mg protein-hr. Data represent means + SE from 3-5 independent
experiments in trplicate. **Significant decrease from treatment with Glut
and DHA, in the presence of Glucose (11 mM) (P-:O, OI).
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LMH cells and 24 h after transfection LMH cells were treated with Glut (50
) and DHA (250 /-M) either alone or in combination for 16 h in the
presence or absence of Glucose (11 or 33 mM). Glucose (33 mM) reduced
the basal1uciferase activity of uninduced LMH cells, Glut alone increased
reporter activity about 1,5- fold over control while DHA alone did not have
any significant effect (Figure 4.6 B). Glut and DHA in combination
significantly increased the expression from pGcALAS9 , 1- Luc in a
synergistic manner that was approximately 5-fold over no treatment control
(PocO.001) (Figure 4.6 B). The induction by Glut and DHA was reduced by
glucose at 11 mM and further reduced by glucose at 33 mM (PocO.Ol)
(Figures 4.6 A and B). Glucose (33 mM) had no effect on basa11uciferase
activity of a pGL3SV40 construct transiently transfected in LMH cells and
treated with increasing concentrations of glucose (11-66 mM) (Figure 4.7).
Effect of glucose analog 2-DOG on reporter activity in LMH cells untreated
or treated with Glut and DHA in the presence or absence of glucose,
Analogs of glucose such as 3-0-methyl glucose (3-0MG) and 2-deoxy
glucose (2-DOG) have been shown to block the inhibitory effect of glucose
on ALAS enzyme activities (Giger and Meyer, 1981). In order to further
characterize the glucose effect on ALAS- l expression I studied the effects
. ""-".c.-
Figure 4.6. Comparative effects of selected chemicals on luciferase
activities in LMH cells transiently transfected with pGcALAS9. Luc.
Following transient transfections, LMH cells were either untreated or treated
with glucose (11 mM or 33 mM) and/or treated simultaneously with Glut, 50
IlM or DHA , 250 IlM alone or in combination for 16 h prior to harvest.
Luciferase, B-gal , and protein concentrations were assayed as described in
Chapter II. Luciferase activities are expressed either as normalized relative
luciferase units (RLU) (A) or as normalized fold induction over untreated
control (B) normalized to B-gal activities and protein concentrations, Data
represent means + SE from 3-5 independent experiments in triplicate.
*Significant increase from all others (P-:0.001). **Significant decrease from
treatment with Glut and DHA (P-:O.Ol).
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Figure 4.7. Effect of glucose on the pGL3SV 40 luciferase activity in
LMH cells. LMH cells were transfected with pGL3SV40-Luc as described
in Chapter II and the effect of increasing concentrations of glucose on
luciferase activity was tested in LMH cells maintained in serum-free
Waymouth' s medium. Briefly, 24 h after transfection, the medium on the
plates was changed to serum-free Waymouth' s medium (containing 11 mM
glucose). LMH cells were then treated with increasing concentrations of
glucose (1, 2 , 5. , 11 44 or 55 mM) to give effective glucose
concentrations of 12 , 13 , 16. , 33 , 55 and 66 mM respectively and
then maintained at 37 for 16 h prior to harvest. Luciferase, B-gal , and
protein concentrations were assayed as described in Chapter II. Luciferase
activities are expressed either as fold induction over untreated control
normalized to B-gal activities and protein concentrations, Data are expressed
as means + SE from 2 independent experiments done in triplicate.
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of the glucose analog, 2-DOG, on Glut and DHA induction and on the
ability of glucose to alleviate this induction, The compound
, 2-DOG, is
taken up by liver cells in the same way as glucose and can be
phosphorylated into 2-DOG- phosphate but cannot be further metabolized.
Hence in its presence we would expect an induction in reporter gene activity
by Glut and DHA even in the presence of inhibitory concentrations of
glucose. LMH cells were transiently transfected with pGcALAS9, Luc as
described in Chapter II, In the presence of2-DOG, induction by Glut and
DHA was higher than induction by Glut and DHA alone (Figure 4, 8),
Effect of selected gluconeogenic or glycolytic substrates on reporter gene
activity in LMH cells, The effect of selected carbohydrates and
metabolizable sugars on pGcALAS9, Luc reporter activity was tested in
LMH cells, Glucose by itself (33 mM) reduced the basalluciferase activity
of untreated cells. Glut and DHA in combination induced the normalized
luciferase activities approximately 4. fold over control (Figure 4.9), This
induction was reduced significantly by glucose (33 mM), frctose (33 mM),
galactose (33 mM), or the gluconeogenic or glycolytic substrates
, glycerol
(33 mM) and lactate (11 mM) (P OOI), but not by the non-metabolizable
sugar sorbitol (33 mM) (Figure 4,9).
. :
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Figure 4.8. Effect of glucose and/or 2-DOG on Glut and DHA-mediated
induction of luciferase activities in LMH cells transiently transfected
with pGcALAS9. Luc. Following transient transfection
, LMH cells were
either left untreated or treated with glucose (Gluc
, 33 mM), 2-deoxyglucose
(2-DOG, 11 mM), and/or treated simultaneously with Glut
, 50 IlM and
DHA, 250 IlM for 16 h prior to harvest. Luciferase
, B-gal activities , and
protein concentrations were assayed as described in Chapter II. Luciferase
activities are expressed as fold induction over untreated control normalized
to B-gal activities and protein concentrations. Data represent means + SE
from 3- 5 independent experiments in trplicate. Significant decrease from
cells treated with Glut + DHA and Glut+DHA+2-DOG+Glucose, P.(0.
(Tukey Kramer).
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Figure 4.9. Effect of selected carbohydrates on Glut and DHA-mediated
induction of luciferase activities in LMH cells transiently transfected
with pGcALAS9. Luc. Following transient transfection, LMH cells were
either left untreated or treated with glucose (33 mM), frctose (33 mM),
galactose (33 mM), glycerol (33 mM), lactate (11 mM) or sorbitol (33 mM)
and/or treated simultaneously with Glut
, 50 IlM and DHA, 250 IlM for 16 h
prior to harvest. Luciferase
, B-gal activities and protein concentrations were
assayed as described in Chapter II, Luciferase activities are expressed as fold
induction over untreated control normalized to B-gal activities and protein
concentrations, Data represent means + SE from 3-5 independent
experiments in trplicate. *Significant increase from others
, P-:O, OOI.
,-Significant decrease from Glut+DHA and
, Glut+DHA + Sorbitol , P-:O.OOI.
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Effect of 8-CPTcAMP on Glut-induced pGcALAS9. 1 reporter gene activity
in LMH cells. Changes in intracellular c-AMP levels have been shown
previously to increase drg-induced porphyrin biosynthesis in CELCs
maintained in serum-free medium (Stephens et aI. , 1978), To determine if
changes in c-AMP levels mediate the glucose effect on ALAS-
, the effect
of increasing concentrations of the cAMP analog 8-( 4-chlorophenylthio)
cyclic adenosine monophosphate (8-CPTcAMP), a long lasting analog of
cAMP, was tested on pGcALAS9. Luc activity in LMH cells. Glut alone
(50 IlM) induced pGcALAS9, Luc activity 1.4-fold as seen before (Figure
6 and 4.9). Increasing concentrations (60
, 200 and 600 
IlM) of8-CPTc-
AMP alone had no effect on pGcALAS9. Luc activity but increased in a
dose-dependent manner the Glut-induction ofpGcALAS9, Luc activity to
about 2. fold (Figure 4. 10).
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Figure 4.10. Effect of 8-CPTcAMP on Glut -mediated induction of
luciferase activities inLMH cells transiently transfected with
pGcALAS9. Luc. Following transient transfection, LMH cells were either
left untreated or treated with Glut (50 
IlM) or 8-CPTcAMP (60, 200 , or 600
IlM) or with a fixed concentration of Glut (50 IlM) and increasing
concentrations of 8-CPTcAMP (60, 200 , or 600 IlM) for 16 h prior to
harvest. Luciferase , B-galactosidase activities (B-gal) and protein
concentrations were assayed as described in Chapter II. Luciferase activities
are expressed as fold induction over untreated control normalized to B-gal
activities and protein concentrations. Data are expressed as means SE from
5 independent experiments in triplicate. *Significant increase from
treatment with 50 IlM Glut alone (P':O. OO 1). The EC was calculated to be
53. 1 IlM 8-CPTcAMP by Non-linear Regression analysis (R = 1.00) using
the Hill, 4 Parameter method.
-e- CPTcAMP (J1M)
.,. .. 
Glut (50 pM) + 8-CPTcAMP (pM)
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t-. 
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200 400 600
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Conclusions
The optimal glucose conditions for the induction of ALAS- l activity
in LMH cells by Glut and DHA were established. Treatment with Glut and
DHA induced ALAS activity many fold over no treatment control in LMH
cells maintained in regular Waymouth' s medium (Figure 4.2), Glucose , in
the absence of serum or hormones , decreased the Glut- and DHA- , and Glut-
and FeNTA- mediated induction of ALAS , in a dose-dependent manner
while the same concentrations of the monosaccharide, sorbitol , had no effect
on the Glut- and DHA- induction of ALAS, From this lack of effect of
sorbitol we conclude that the decrease in ALAS activity observed with
glucose could not be attrbuted to changes in cell volume , such as that
occurrng due to addition of large amounts of solute, but due to a specific
effect of glucose.
I tested whether the effect of glucose occurs on ALAS- l gene
expression. This was addressed by determning the effects of glucose and
other metabolizable sugars on LMH cells transiently transfected with an
ALAS- l promoter-luciferase (Luc) reporter constrct. Treatment for 16 h
with Glut (50 
IlM) and DHA (250 IlM), synergistically induced
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approximately 5-fold over control , the ALAS- l promoter-reporter activity of
a constrct containing approximately 9. 1 kb of chick ALAS- l 5' flanking
region and 5' UTR attached to a Luc reporter gene (pGcALAS9. Luc)
(Figures 4.6 A and B). Glucose (11 or 33 mM), in a dose-dependent manner
decreased Glut and DHA-mediated up-regulation ofpGcALAS9. Luc
(Figure 4.6). Gluconeogenic sugars such as frctose , galactose or glycolytic
compounds, such as glycerol and lactate, but not the non-metabolizable
sugar, sorbitol , mimicked the "glucose effect" on ALAS- I. Sorbitol served
as a negative control as in its presence at concentrations equal to those of the
other carbohydrates , promoter activity was induced to similar extents as that
obtained with Glut and DHA, 8-CPTcAMP , a long-lasting analog of cAMP
potentiated the induction ofpGcALAS9, Luc by 50 f.M Glut suggesting
that the "glucose effect" could be mediated by decreases in cAMP levels.
These results establish that glucose or gluconeogenic or glycolytic
substrates can down-regulate hepatic ALAS- l through a mechanism that
requires the first 9, 1 kb of the 5' flanking and 5' UTR region of the ALAS-
gene. These effects were observed in the absence of insulin, glucagon, other
.j.
hormones or serum. I conclude that LMH cells provide an excellent model
for delineating the mechanism of the "glucose effect" on ALAS-
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CHAPTER V
CHARACTERIZATION OF THE UPSTREAM REGULATORY
REGION OF CHICK ALAS-1 GENE IN LMH CELLS: STUDIES ON
EFFECTS OF HEME, GLUT AND DHA
Introduction
Under normal physiological conditions
, "
free" heme levels are low
and tightly regulated, as toxicity can occur with increased cellular
concentrations of unincorporated heme (Balla et aI. , 2003; Maya-Monteiro et
aI. , 2004; Gonzalez-Michaca et aI. , 2004), However, coordinate increases in
heme and cytochrome P-450(s) are required for induction by drugs and other
chemicals of cytochrome P-450(s) in liver and other tissues (Kihara et aI.
1999), This is achieved by induction of ALAS- l which provides an adequate
supply of heme for the generation. of functional cytochrome holoproteins
(Granick et aI. , 1975; May et aI. , 1986). Free heme is envisioned to repress
hepatic ALAS- l by a number of negative feedback mechanisms , including
reduction of transcription (Srivastava et aI. , 1990; Sassa and Nagai , 1996),
reduction ofmRA stability (Hamilton et aI. , 1988; Cable et aI. , 2002) and
inhibition of the transport of the pre-ALAS- l into the mitochondria (Lathrop
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and Timko, 1993) (p. 7). Direct inhibition of ALAS activity by heme has not
been found at reasonable heme concentrations (Wolfson et aI.
, 1979),
Results of studies on the effect of heme on ALAS- l gene transcription
have been conflicting in part due to coinciding effects of heme on ALAS-
mRA stability (Srivastava et aI. , 1988; Srivastava et aI. , 1990; Hamilton et
aI. , 1991), In Chapter III, Glut and DHA in combination were shown to
synergistically up-regulate ALAS- l enzye activity in LMH cells as
detected by spectrophotometr. This up-regulation was repressed by
exogenous heme (20 
IlM), Due to uncertainties implicit in the several
potential mechanisms of the heme repressive effect described above
, the
transcriptional regulation of ALAS- l by heme and chemicals that affect
heme synthesis were studied using promoter-reporter constrcts. In this
Chapter, the cis-acting elements in the 5' - flanking region and 5' -UTR region
of ALAS- l that mediate heme-dependent repression of ALAS- l gene
. !
transcription were studied with the long-term goal of identifying the heme
repressive element(s) that regulate ALAS- l gene transcription,
In contrast to heme, there is much experimental evidence that ALAS-
1 gene expression is increased directly by drgs (Hamilton et aI. , 1988;
Hamilton et aI. , 1991; Louis et aI. , 1998; Jover et aI. , 2000), A recent study
3;:.
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in LMH cells has demonstrated that induction of ALAS- l by drgs involves
the chick xenobiotic-sensing receptor (CXR), a chick homolog of the
constitutive androstane receptor, (CAR) (Fraser et aI. , 2002). The
transcriptional activation of cALAS- l gene by CXR has been shown to
occur via two 175 bp and 167 bp drg responsive enhancer sequences
(DRES) located at - 312 to - 137 bp and - 592 to - 426 bp upstream
of the transcriptional start site, These DRES' s work independently of each
other and contain functional direct repeat (DR) 4 and DR5 tye recognition
sequences for nuclear receptors (Fraser et aI. , 2002). Characterization of
these DRE' s does not exclude a role fqr a regulatory heme pool in
modulating the extent of induction by drugs (p. 7), This is partly due to the
fact that the "free" or "regulatory" heme pool is presumed to be small and to
turn-over rapidly (Ketterer et aI. , 1976; Vincent et aI. , 1989; Muller-eberhard
and Fraig 1993), making it practically impossible to measure. Indeed
, no
direct measure of such a pool has been accepted in the field. The level of
activity of ALAS- l is taken as perhaps the most sensitive indirect estimate
of the size of the regulatory heme pool (Sassa and Nagai , 1996). Another
proposed measure is the degree of saturation of trtophan pyrolase by
heme (Bonkovsky et aI. , 1990).
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Indirect evidence for the effect of heme pool depletion on induction of
ALAS- l is obtained from heme-deficient mice where heme-deficiency
augmented drug-mediated induction of ALAS mRA (Jover et aI. , 2000),
In this study, treatment of mice deficient in heme synthesis , with drugs that
induce CYP and increase the demand for heme, resulted in a synergistic up-
regulation of ALAS- l mRA levels (Jover et aI., 2000). Another line of
evidence for the effect of regulatory heme pool comes from studies of cells
in culture, assessing effects on enzye activity of chemicals that inhibit
heme synthesis (Sassa 1982; Kolluri et aI. , 1999; Cable et aI. , 2000). In these
studies, treatment of cells with inhibitors of heme synthesis, in combination
with drugs that induce CYP and increase the demand for heme, resulted in
synergistic increases in ALAS- l enzye activity (Sassa 1982; Kolluri et aI.
1999; Cable et aI. , 2000), Synergistic effects of the combination of
chemicals as described above might be explained by their effects on the
regulatory heme pool (p. 7), by a direct effect of these chemicals on the
expression of ALAS- l gene, or by a combination of both.
The question of heme regulation of basal and drg-induced ALAS-
gene transcription was approached by investigating, in LMH cells , the
effects of Glut in combination with the inhibitor. of heme synthesis , DHA
and/or heme on ALAS- l promoter-reporter (Luc) constrcts
transiently/stably transfected and treated with the above mentioned
chemicals as described in detail next.
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Results
Effects of Glut or DHA alone or in combination on ALAS/Luc
constrcts. For characterization and delineation of the effects of heme and
drugs on ALAS- l promoter, the 9. 1- and a 3. kb of the 5' flanking and 5'
untranslated (UTR) region of chick ALAS- l fused upstream of the reporter
(luciferase) gene of a pGL3basic vector (Promega, Madison, WI), as
described in Chapter II, were used. These ALAS- l constrcts are termed
pGcALAS9. Luc and pGcALAS3. Luc , respectively. In Chapter IV, Glut
in combination with DHA, an effective inhibitor of ALA dehydratase (Cable
et aI. , 2000), the second enzye of heme biosynthesis, synergistically
induced pGcALAS9, Luc activity 5-fold over control (Figure 4,6 B). In the
experiments described in this Chapter, the question of drg and heme
regulation of ALAS- l was approached by studying transfections of these
ALAS- l constrcts in LMH cells, which have been shown to be a good
model for studies of heme biosynthesis and regulation of ALAS- l (Chapter
III), The effects of Glut or DHA alone or in combination were tested in
LMH cells transiently transfected with pGcALAS9, Luc , and compared
with the effect of the selected chemicals on the shorter constrct-
pGcALAS3. Luc (Figure 5. 1). Glut alone (50 
IlM) for 16 h led to a 3-fold
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Figure 5.1. CALAS-Luc constructs and effects of Glut and DHA on Luc
expression (A) The 5' - flanking and 5' -UTR region of chick ALAS- l gene
showing candidate regulatory elements and strctures of cALAS-
constrcts used, Numbering starts at the transcription start point (+ 1),
Comparative effects of selected chemicals on luciferase activities in LMH
cells transiently transfected with pGcALAS3. Luc (B) or pGcALAS9.1-
Luc (C), Following transfections , LMH cells were either left untreated or
treated with Glut, 50 IlM or DHA , 250 IlM or the combination for 16 
Cells were harvested and luciferase, B-galactosidase activities (B-gal) and
protein concentrations were assayed as described in Chapter II. Luciferase
activities are expressed as fold induction over untreated control normalized
to B-gal activities and protein concentrations, Results are means + SE from
5 independent experiments in triplicate. This experiment was repeated six
times with essentially the same results, *Differs from None or DHA alone
, P
-: 0.01, In B , the two groups treated with Glut did not differ significantly
from one another. **Differs from others , P -:0,001. AP, activator protein;
CoreB/ AP- , activator protein with 4 bp extension; TRE, TP A-response
element; CREB , cAMP response element. Recognition sites for enzymes
Xho I, Sma I, and Hind III, used for plasmid constrction(s) are also shown.
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increase in luciferase activity in cells transfected with pGcALAS3. Luc
-(Figure 5. 1 B). A lesser increase (I.5- fold) was obtained with 50 
IlM Glut
alone in cells transfected with pGcALAS9. Luc (Figure 5. 1 C). In cells
transfected with pGcALAS3, Luc , the combination of Glut (50 
IlM) and
DHA (250 
IlM) did not significantly increase luciferase activity compared
with treatment with 50 IlM Glut alone (Figure 5. 1 B). In contrast, in cells
transfected with pGcALAS9, Luc, the combination of 50 IlM Glut and 250
IlM DHA produced a synergistic induction in luciferase activity compared
with 50 IlM Glut or 250 
IlM DHA alone (P OOI) (Figure 5. 1 C).
The synergistic induction by Glut and DHA ofpGcALAS9. Luc , but
not ofpGcALAS3. Luc, suggest that there are negative element(s) in the
5 to - 1 kb region of ALAS- l 5' flanking region that repress Glut
induction in the absence ofDHA, Interestingly, DHA alone (250 
IlM) did
not have any effect on pGcALAS9.1-Luc activity (Figure 5. 1 C), This is
probably because
, it has been shown that even though DHA inhibits de novo
heme biosynthesis
, it does not affect the regulatory heme pool 
per se (Giger
and Meyer, 1983; Russo et aI. , 1994; Kappas et aI. , 2000), which may exert
a regulatory effect on the - 5 to - 1 kb region, But Glut and DHA in
combination increase the demand for heme because barbiturate-like drugs
' "
. .
_'0
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such as Glut induce CYP mRA and apoprotein synthesis (Jover et aI.
1996; Handschin and Meyer, 2000; Kappas et aI. , 2000) the latter by binding
heme decreases the heme pool further (p. 7), leading to the synergistic
activation ofpGcALAS9, Luc , as obtained in the presence of Glut and
DHA (Figure 5. 1 C).
Glut and DHA dose-res onse. Because there was no synergistic effect of
Glut (50 
IlM) and DHA (250 IlM) on pGcALAS3.5-Luc, I investigated
whether Glut and DHA at other concentrations can affect pGcALAS3, Luc,
I first assessed the effect of increasing concentrations of Glut alone (0- 1000
M). 50 /-M Glut gave maximal up-regulation ofpGcALAS3, Luc (Figure
2 A). The decrease in luciferase activity observed with 1000 IlM Glut 
was
probably due to toxicity at the higher concentration
, as reflected by
decreased B-gal activity and protein levels. Increasing concentrations of
DHA 000 IlM), had no effect on Glut (50 IlM)-induced reporter gene
expression from pGcALAS3, Luc (Figure 5,2 B), indicating that
pGcALAS3. Luc was unable to be synergistically induced by DHA,
Because DHA, an effective inhibitor of heme synthesis (Sassa and
Kappas , 1982; Giger and Meyer, 1983; Kappas et aI. , 2000), produced a
synergistic increase with Glut of pGcALAS9 , Luc, but not of
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Figure 5. 2. Effect of increasing concentrations of Glut alone 
(A), 
DHA in combination with a fixed concentration (50 
11M) of Glut (B)
on luciferase activities in LMH cells transiently transfected with
pGcALAS3. Luc. Following transfection, LMH cells were either left
untreated or treated with increasing concentrations of Glut (0
, 150
250 , 500 or 1000 
IlM) or Glut (50 IlM) and DHA (0 , 250, 500 , 750 or
1000 IlM) and harvested after 16 h, Luciferase-
, B-gal activities and
protein concentrations were assayed as described in Chapter II. Results
are means SE from 3-5 independent experiments in triplicate.
Luciferase activities are expressed as fold induction over untreated
control normalized to B-gal and proteins. Values for all concentrations of
Glut? 0 IlM except 1000, differ from 0
, p
OO1.
9 ..
= =
1= =
- N
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1= =
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N =
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pGcALAS3. Luc (Figures 5. 1 B and C), it seemed likely that element(s)
involved in the heme-mediated repression of chick ALAS- l gene occur in
the - 5 to - 1 kb region. Synergistic activation ofpGcALAS9. Luc by
Glut and DHA (Figure 5, 1 C) might be due to a decrease in the regulatory
heme pool that normally mediates heme repression (p. 7), through a
mechanism that requires the - 5 and - 1 kb region of the chick ALAS-
gene,
In order to determne if the effect ofDHA on pGcALAS9. Luc was
mediated through its ability to decrease heme levels in the cells , we assessed
the induction by Glut and DHA in the presence of exogenous heme (Figures
3 A and B). Heme (20 IlM 16 h) repressed the basalluciferase activity of 
pGcALAS9, Luc which was reduced by more than 75% (Figure 5.3 B),
indicating heme-mediated repression ofpGcALAS9. Luc. The luciferase
activity ofpGcALAS9.1-Luc that had been increased by treatment with Glut
and DHA, was also repressed, by the addition of heme (20 
IlM), to a level
similar to that obtained by Glut alone (Figure 5.3 B). In contrast, there was
no effect of heme either on the basal or Glut- and DHA-induced reporter
gene expression ofpGcALAS3. Luc (Figure 5.3 A), suggesting that the -
5 to - 1 kb region of the chick ALAS- l promoter contains one or more
124
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Figure 5.3. Comparative effect of exogenous heme on luciferase
activities in LMH cells transiently transfected with pGcALAS3. Luc
(A) or pGcALAS9. Luc (B). Transfections, preparation of and treatment
with Glut and DHA, and heme were performed as described in Chapter II.
Cells were harvested after 16 h of exposure to selected chemicals and
assayed as described in Chapter II, Results are means + SE from 8
independent experiments in trplicate. **Differs from Glut + DHA, or Heme
alone, P -: 0.001. *Differs from others, P -: 0,001. In A, the three groups
treated with Glut did not differ significantly from one another. ,- Differs
from None , Heme , or DHA alone, P -: 0.01.
None
Hem e (20 IJM)
. G lu t(50 IJM)
...
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cis-acting elements that mediate heme-dependent repression of ALAS-
The fact that reporter gene activities were unaffected by heme in Figure 5.
, suggests that heme at the concentration used (20 
IlM) was not toxic to
LMH cells, a finding consistent with other results (Gabis et aI.
, 1996;
Kolluri et aI. , 1999). The induction ofpGcALAS9, Luc by Glut alone
(Figures 5. 1 C and 5,3 B), was less than the induction of the 3.5 kb cALAS-
1 promoter constrct by 50 IlM Glut alone (Figures 5. 1 Band 5,3 A)
suggesting that there are silencer elements that repress drug induction in the
5 to - 1 kb heme-responsive region.
Effect of increasing concentrations of heme on pGcALAS9. Luc activity:
LMH cells transiently transfected with pGcALAS9. Luc were treated with
heme (0 , 5 , 10 , 15 40) IlM heme for 16 h, cells harvested, and luciferase
gal activities and proteins were measured as described in Chapter II.
Increasing concentrations of heme from 0 to 
15 M reduced luciferase
activity in a dose-dependent manner (Figure 5.4). Significant down-
regulation by heme was noted at 10 M and 15 IlM (P-:O,OOI), and the effect
(54% repression ofluciferase activity) was 
maximal at 20 M (Figure 5.4).
Hence, in further experiments 20 IlM heme was the concentration used.
..c
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Figure 5.4. Effect of increasing concentrations of heme on pGcALAS9.
Luc in transiently transfected LMH cells. LMH cells transiently
transfected with pcALAS 9. 1- Luc were treated with increasing
concentrations of heme (0 , 5 , 10 , 15 20 and 40 IlM) in DMSO and
maintained at 37 C for 16 h, after which cells were harvested and used to
measure luciferase gal activities and proteins. Luciferase activities are
expressed as fold induction over DMSO-treated control normalized to
proteins. Results are means SE from 3-5 independent experiments in
triplicate, *Differs from cells transfected with pGcALAS9, Luc and treated
with 0 IlM heme , p-c0.001,
..... . . =
"t 
... 1'
1.2
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Effect of selected chemicals that induce CYP on pGcALAS9. 1 in stably
transfected LMH cells: Recently, it has been shown in LMH cells that
treatment with selected drgs increases ALAS- l mRA levels and
luciferase activity and the effects are mediated, at least in part, by drg-
responsive enhancer sequences (DREs) in the 5' flanking of ALAS- l (Fraser
et aI. , 2002). In my next studies , pGcALAS9. Luc activity was measured in
stably-transfected LMH cells after exposure of cells to drugs (Fraser et aI.
2002). Stable transfections were used since in preliminary studies
, as in
other studies , stable incorporation of the constrcts was found to provide
more consistent and larger chemical-induced changes in Luc activities
(Alam et aI. , 1994; Alam et aI. , 1995; Shan et aI. , 2002; Alam 2002). Seven
chemicals were screened for their ability to induce the pGcALAS9. Luc
(Figures 5. 5 A and B). Metyapone (Met; 400 
IlM), AlA (250 IlM), and Glut
(50 IlM) induced pGcALAS9. Luc activity (~ fold) as compared to
control (Figure 5.5 B), There was no effect of20 IlM PCN and a decrease
with 10 IlM RU-486 and 50 IlM Dex, as compared to control (Figure 5.5 B),
Subsequent work was done with 50 IlM Glut as it gave consistent and
measurable up-regulation ofpGcALAS9. Luc (Figures 5.5 A and B) at a
lower concentration than other phenobarbital-like chemicals.
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Figure 5.5. Comparative effects of selected chemicals that induce CYP
on pGcALAS9. Luc activity in stably transfected LMH cells shown as
normalized RLU (A) and normalized fold induction (B). LMH cells
stably transfected with pGcALAS9. Luc as described in Chapter II were
treated with chemicals and maintained at 37 C for 16 h, after which cells
were harvested and used to measure luciferase gal activity and proteins as
described in Chapter II. Concentrations of the selected chemicals were as
follows: Glut - 50 
IlM; metyrapone (Met) - 400 /lM; allylisopropyl
acetamide (AlA) - 250 /lM; phenobarbital (PB-Na) - 600 /lM; RU486 - 10
IlM; and dexamethasone (Dex) - 50 IlM respectively, Results are means +
SE from 3-5 independent experiments in trplicate, Luciferase activities are
expressed as relative luciferase activity (RLU) or fold induction over
untreated control , normalized to proteins. *Differs from none , P-:O.Ol. #
Differs from none, P-:O.OI.
",.
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Delineation of the - 1 to - 5 kb cALAS- l region: Since heme-repression of
drug-induced reporter activity can be used as a tool to delineate the heme-
repressive region of ALAS- , deletion constrcts in the heme-responsive
region were made starting from the Xho I site (-9067 bp) (Figure 5. 6),
Detailed sequence information or restriction map of the -9.1 to - 5 kb
region was not known when these studies were begun. Therefore , I screened
and chose a number of restriction enzyes that were non-cutters in the
proximal- 5 kb or in the vector (pGL3 Basic). PGcALAS9, Luc was
completely digested with Xho I and subsequently with different enzyes
and we looked for two bands that can be easily separated on agarose gels.
Xho I and Pml I or Pac I restriction endonuc1eases were chosen based on the
above mentioned criterion and deletion constrcts were generated as
described in Chapter II and as shown in Figure 5.6. The resulting deletion
constrcts and the - 1 to - 5 kb of chick ALAS- l 5 flanking region were
sequenced (single strand), collated with the +0,082 to - 5 kb sequence, and
analyzed for putative regulatory elements by computer sequence analysis
tools, The approximately 9, 1 kb sequence (Appendix E) was also confirmed
with a 15 kb sequence of chick ALAS- l promoter that was recently
published (Fraser et aI. , 2002).
, ;'' '
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Figure 5.6. The 5' flanking and 5' UTR region of chick ALAS-1 gene
showing candidate regulatory elements and structures of cALAS-
constructs. Numbering starts at the transcription start point (+ 1). Only sites
with complete identity to known consensus regulatory elements are shown.
Abbreviations used: AP, activator protein (Guberman et aI. , 2003);
CoreB/AP- l (Alam 2002), activator protein with 4 bp extension; TRE
, TPA-
response element (Alam and Denz 1992); CREB
, cAMP response element
(Giono et aI. , 2001). A partial restrction endonuclease map of the chick
ALAS- l promoter region is also presented. Recognition sites for restriction
endonucleases Xho I (X), Pml I (P), Pac I (Pa), Sma I (S), BspM I (Bs) and
Hind III (H) are shown.
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Effects of Glut and DHA, and/or heme on ALAS-Luc constrcts in
transiently-transfected LMH cells: The effects of Glut (50 
IlM) and DHA
(250 IlM) and/or heme on ALAS-Luc constrcts were tested in LMH cells
transiently transfected with pGcALAS9,
, 7. , and 6, Luc , as described in
Chapter II. Heme (20 !JM) repressed basalluciferase ofpGcALAS9.
, 7.
and 6, Luc to 45% , 50%, and 53% of control , respectively (Figure 5,7 A
and B), This effect of heme to repress could also be seen on Glut and DHA-
induced luciferase activity ofpGcALAS9.l- and pGcALAS6. Luc , which
were reduced to 11 % , and 10% of Glut- and DHA-induced levels in the
presence of heme (Figures 5, 7 A and B).
The 7,6 kb constrct showed similar heme-dependent repression as
the 9, 1 and 6.3 kb constrcts ofbasalluciferase activity (50 %) but it could
not be induced by Glut and DHA (I.07 + 0. 18-fold), Therefore, repression
by heme in the presence of Glut+ DHA showed repression (61 %) that was
similar to basal repression by heme (50% of basal activity) (Figure 5.7 B),
Comparative effects of Glut and DHA, and heme on ALAS/Luc constrcts
stably:'transfected LMH cells: Effects of Glut (50 
IlM) + DHA (250 IlM),
and/or heme (20 !JM) or DMSO (MezSO) alone on ALAS-Luc constrcts
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Figure 5.7. Comparative effects of Glut and DHA, and heme on
ALAS/Luc constructs in transiently transfected LMH cells shown 
normalized RLU (A) or normalized fold induction (B), LMH cells
transiently transfected with selected ALAS-Luc constrcts were treated with
chemicals and maintained at 37 C for 16 h, after which cells were harvested
and used to measure luciferase activity and proteins. Concentrations of the
selected chemicals were as follows: Glut
, 50 IlM; DHA, 250 IlM; and heme
20 IlM. Luciferase activities are expressed as RLU or fold induction over
untreated control normalized to gal and proteins. Results are means + SE
of 6 independent experiments in triplicate. *Differs from cells transfected
with pGcALAS9. 1- or 6. Luc and treated with Glut and DHA
, P-cO,OOI. #
Differs from all cells transfected with pGcALAS9. 1- or 6. Luc, P-CO, OOI.
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Glut+DHA
Heme
None
Treatment 0
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were also tested in LMH cells stably-transfected with pGcALAS9. , 7.
3- and 3. Luc , as described in Chapter II, Several independent single
colonies were tested and only those found to give similar results to that
shown previously for transient transfections (Figures 5.7 A and B) were used
(Figures 5.8 A and B). DMSO (Me SO) alone had no significant repressive
effect on luciferase activity of the different clones , but 20 f.M heme
dissolved in DMSO repressed luciferase ofpGcALAS9. , 7.6- and 6. Luc
to 35%, 70% , and 68% of control , respectively, whereas the luciferase
activity ofpGcLAS3. Luc was unaffected (Figue 5.8 A). This effect of
heme to repress was seen more strkingly on Glut and DHA-induced
luciferase activity ofpGcALAS6, Luc , which was substantially reduced to
19% in the presence of heme (Figures 5.8 A and B). However, as shown
before (Figure 5,3 A) the Glut induced activity ofpGcALAS3. Luc is not
affected by the addition of20 IlM heme (Figure 5, 8 A and B). This suggests
that the - 5 to - 3 kb 5' flaning region of ALAS- l contains one or more
cis-acting element(s) that mediate heme-repression of basal and drug-
induced luciferase activity.
Effect of increasin concentrations of Glut on GcALAS6. Luc: Since the
6 kb constrct could not be induced by Glut and DHA (Figures 5,7 Band
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Figure 5.8. Comparative effects of Glut and DHA, and heme on
ALAS/Luc constructs shown as normalized RLU (A) or normalized fold
induction (B), LMH cells stably-transfected with ALAS-Luc constrcts as
in Chapter II were treated with chemicals and maintained at 37 C for 16 h
after which cells were harvested and used to measure luciferase activity and
proteins as described in Chapter II, Concentrations of the selected chemicals
were as follows: Glut, 50 IlM or DHA, 250 IlM and heme , 20 IlM. Results
are means + SE of 3-5 independent experiments in triplicate. Luciferase
activities are expressed as RLU or fold induction over untreated control
normalized to proteins. *Significant decrease from cells transfected with
pGcALAS9. 1- or 6. Luc and treated Glut and DHA, P-:O.OOI. # Significant
increase from all cells transfected with pGcALAS9. 1- or 6, Luc , P-:O.OOI.
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8 B , the effect of increasing concentrations of Glut alone (50- 500 IlM) 
pGcALAS6. Luc was determned (Figures 5,9 A and B). Glut (50 IlM and
100 IlM) increased pGcALAS6, Luc activity ~ 3- and 3. fold
respectively, which was then maintained at ~3, fold at 250 and 500 f.M
Glut (Figures 5.9 A and B). The pattern of induction ofpGcALAS6, Luc
by increasing concentrations of Glut (50- 500 IlM) (Figure 5.9 B) was similar
to that seen before for pGcALAS3, Luc (Figure 5.2 A) suggesting that the
3 kb constrct retains drg-induction as well as heme-mediated repression
of basal and Glut and DHA-mediated induction similar to the - 1 kb
constrct (Figures 5.7 A and Band 5.8 A and B),
In summary, the data presented till now provide supporting evidence
that the +0.082 to -3447 bp region in the 5' flanking and 5' UTR of ALAS-
plays a role in drug-mediated induction of chick ALAS- 1 as shown
previously (Fraser et aI. , 2002) and that the -3448 to -6266 bp 5' -flanking
region mediates heme-responsiveness. In addition , the observation that the -
7676 bp to -6267 bp region (as shown in the 7,6 kb construct) showed heme
repression of basal activity but could not be induced by Glut and DHA
suggested non-heme-dependent repression of drug induction (Saatcioglu et
aI. , 1994).
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Figure 5.9. Effect of increasing concentrations of Glut on pGcALAS6.
Luc shown as normalized relative luciferase activity (A) and normalized
fold induction (B). LMH cells stably transfected with pGcALAS6, Luc
were either left untreated or treated with increasing concentrations of Glut
, 50 , 250 , or 500 IlM) and maintained at 37 C for 16 h, after which cells
were harvested and assayed for luciferase activity and proteins as described
in Chapter II. Luciferase activities are expressed as relative luciferase
activity or as fold induction over untreated control normalized to proteins,
Results are means + SE of 3-5 independent experiments in triplicate. Values
for all concentrations of Glut? 0 JlM differ from 0 , P-:O. O 1. The EC was
calculated to be 40,92 IlM Glut by Non-linear Regression analysis (R
953) using the Hill, 4 Parameter method.
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Effect ofPB, Glut, and heme on Drug-Responsive Element (DRE)
constrcts of chick ALAS- 1 gene: As mentioned before , two separate (176
bp and 167 bp) drg-responsive enhancer sequences (DRE' s) upstream from
the - 1 kb region have been shown recently to playa key role in drug-
induction of chick ALAS- l (Fraser et aI. , 2002). In an effort to insert the
drug-responsive elements (DRE) upstream of the heme responsive region of
ALAS- , a 522 bp region containing the 167 bp enhancer sequence with
primers containing Mlu I sites was PCR amplified (Appendix E). This 522
bp PCR product was inserted into the Mlu I site of the multiple cloning sites
ofpGL3SV40 promoter, pGcALAS 9.1-Luc , and pGcALASO. Luc
constrcts upstream of the Xho 1 site in its natural orientation in the cALAS-
1 sequence (Chapter II).
The effects of drgs on the above constrcts were tested and
compared with their effects on constrcts without the DRE in transiently
transfected LMH cells (Figures 5.10 A and B), As described previously
(Fraser et aI. , 2002), 500 IlM Glut increased pGL3-SV 40+DRE activity 31-
fold (Figure 5. 10 B), as compared with vehicle-treated control. PB- N a (600
IlM) and Glut (50 j.M) induced to a lesser extent i. e, 6.5- and 16-fold
respectively over controls (Figure 5.1 0 B).
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Figure 5.10. Comparative effect of drugs on pGL3-SV40 promoter
constructs without and with 522 bp PCR product containing cALAS-
167 bp DRE in transiently-transfected LMH cells. Data are shown as
normalized relative luciferase activity (A) and normalized fold induction
(B). LMH cells were plated on 24-well (1.4 cm) plates at a density of 0.75 X
. Transfections , preparation of and treatment with Glut and PB-Na were
performed as described in Chapter II. LMH cells were harvested after 16 h
of exposure to selected chemicals and assayed as described in Chapter II.
Concentrations of the selected chemicals were as follows: Glut, 50 or 500
IlM phenobarbital (PB), 600 IlM. Results are means SE of 7 independent
experiments in trplicate. *Differs from Glut, or PB-Na treated LMH cells
transfected with pGL3-SV40 promoter without DRE or untreated cells
transfected with pGL3-SV40+DRE, P -( O,OOI.
Glut (500 p.M)
Glut (50 p.M)
PB (600 p.M)
None
Treatments 0
Glut (500 11M)
Glut (50 11M)
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In contrast, there was no significant effect of the chemicals on pGL3-SV 40
promoter constrct (Figures 5, 10 A and B) without the DRE.
The effect of Glut (50 
IlM) and PB-Na (600 IlM) alone or Glut (50
IlM) in combination with heme was tested on pGcALAS9. Luc +DRE and
compared with their effects on pGcALAS9. Luc. There was no major
difference in the basal activity of the two 9, 1 constrcts with and without
DRE (Figure 5. 11 A). Addition of the DRE increased the induction by 50
IlM Glut (1,6 to 4. fold) and by 600 IlM PB-Na (from none to 3. fold)
(Figure 5, 11 B). 20 M Heme repressed Glut induction ofpGcALAS9.
Luc by 53%.
Next the effect ofDRE addition on the shorter ALAS- l constrct
pGcALASO. Luc , a constrct that is sufficient for ALAS- l basal promoter
activity (TJ Sadlon unpublished communication), was tested and compared
with the constrct without the DRE (Figures 5. 12 A and B), Neither heme
(20 IlM) nor Glut (50 
IlM) had any effect on pGcALASO. Luc constrct
without the DRE (Figures 5, 12 A and B), Interestingly, Glut (50 IlM)
increaseq pGcALASO, Luc+DRE activity only 3. fold (Figure 5.12. B),
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Figure 5.11. Comparative effect of drugs on pGcALAS9. Luc
constructs without and with 522 bp PCR product containing cALAS-
167 bp DRE in transiently-transfected LMH cells. Data are shown as
normalized relative luciferase activity (A) and normalized fold induction
(B). Transfections , preparation of and treatment with selected chemicals
were performed as described in Chapter II. LMH cells were harvested after
16 h of exposure to selected chemicals and assayed as described in Chapter
II, Concentrations of the selected chemicals were as follows: Glut, 50 IlM or
PB- , 600 IlM and heme , 20 IlM, Results are means SE of7
independent experiments in triplicate. *Differs from Glut treated LMH cells
transfected withpGcALAS9. Luc+DRE, P -( 0,01.
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Figure 5.12. Comparative effect of drugs on pGcALASO. Luc
constructs without and with 522 bp PCR product containing cALAS-
167 bp DRE in transiently-transfected LMH cells. Data are shown as
normalized relative luciferase activity (A) and normalized fold induction
(B), Transfections , preparation of and treatment with selected chemicals
were performed as described in Chapter II, LMH cells were harvested after
16 h of exposure to selected chemicals and assayed as described in Chapter
II. Concentrations of the selected chemicals were as follows: Glut
, 50 IlM
and heme , 20 f.M. Results are means SE of 7 independent experiments in
triplicate, *Differs from Glut treated LMH cells transfected with
pGcALASO, promoter constrct without DRE, Po: 0, 01.
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Conclusions
The effects of drgs and heme on several constrcts containing chick
ALAS- l 5' - flanking and 5' -UTR region attached to a reporter (Luc) gene
were tested by transient and stable transfections in LMH cells, Since the
combination of 50 IlM Glut and 250 IlM DHA produced a synergistic
upregulation of ALAS enzye activity in LMH cells in Chapter III, Glut
alone, DHA alone or in combination, were tested in cells transiently
transfected with pGcALAS9.1-Luc or pGcALAS3. Luc (Figure 5.1 Band
C), 50 IlM Glut increased pGcALAS3. Luc (3-fold) but there was no
further effect ofDHA (0, 250 , 500 , 750 IlM) or heme (20 IlM) 
pGcALAS3, Luc (Figure 5,2 A and B and Figure 5,3 A). Searches of the
entire 9, 1 kb sequence (Appendix E) revealed no consensus DR4 or DR5
tye recognition sequences for nuclear receptors that have been shown to be
important for drug induction ofCYP2Hl and ALAS- l (Dogra et aI. , 1998;
Handschin et aI. , 2000; Fraser et aI. , 2002) ,This suggests that the first 3.5 kb
of cALAS- l 5' flanking and 5' UTR region of chick ALAS- l contains non-
DREelements that contrbute to drug-mediated induction of the gene, The
Glut-mediated induction of the 3.5 kb and 6.3 kb constrcts (~3-fold) was
found to be remarkably consistent in this study in both stable and transiently
, .
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transfected LMH cells (Figures 5.2 and 5.9). A similar induction by Glut
mediated by the non-DRE-containing upstream region of chick ALAS-
gene was also reported by another group (Fraser et aI. , 2002). The
observation that increasing concentrations ofDHA (0 , 250 , 500 , 750 IlM) 
20 IlM heme had no effect on 50 IlM Glut-induced reporter pGcALAS3,
Luc activity (Figures 5.2 and 5,3) leads to the conclusion that drg induction
is separate from the heme responsive region and is mediated through non-
DRE element(s) in the first 3,5 kb promoter region of ALAS-
PB and other potent porphyrinogenic chemicals such as AlA, or Glut
increased pGcALAS9. Luc activity approximately 1.5- fold over control
(Figures 5.3 and 5.5 B). As seen before for ALAS enzye activity (Figures
2 and 3.6), 250 IlM DHA alone had no effect pGcALAS9, Luc activity
but the combination of 50 IlM Glut and 250 IlM DHA for 16 h produced a
synergistic up-regulation, which was repressed by the addition of 20 IlM
heme (Figure 5.3 B).
Dose-response studies showed that the heme effect on pGcALAS9,
Luc was dose-dependent and reached a maximum at 20 11 heme, which
was maintained at 40 IlM heme (Figures 5.4 A and B). The ability ofDHA
an inhibitor of heme biosynthesis, to synergistically up-regulate ALAS-
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gene expression and heme to down-regulate basal and Glut-and DHA-
induced luciferase activity suggested that the amount of heme in the cell can
regulate basal ALAS- l and also determine the extent of drg induction.
Deletion constrcts of the heme responsive -9.1 to - 5 kb region were
generated and tested. Addition of 250 IlM DHA in combination with 50 IlM
Glut induced pGcALAS6.3Luc 5. fold, similar to that ofpGcALAS9, Luc
(4.4-fold) (Figure 5. 7 B). Heme (20 IlM) also repressed basal and Glut- and
DHA-induced pGcALAS6, Luc activity, as in pGcALAS9. Luc
suggesting that the 2.8 kb region in the - 3 to - 5 kb 5 flanking region of
ALAS- l contains element(s) that determne heme responsiveness (Figures
7 and 5.8 A and B). The pattern of induction ofpGcALAS6. Luc by
increasing concentrations of Glut is similar (~ fold) to that observed for
pGcALAS3. Luc (Figure 5,9 A and B vs. 5.2 A). For unkown reasons , the
6 kb ALAS- l constrct could not be induced significantly by Glut and
DHA, even though it showed heme-dependent repression (50% of basal
activity) (Figure 5,7). Further work is needed to establish if the non heme-
dependent repression of drug induction in pGcALAS7. Luc is mediated by
the AP- l element(s) that are present in the - 6 to - 3 kb region of ALAS-
(Appendix E) (Saatcioglu et aI. , 1994).
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Discussion of heme effects on - 3 to - 5 kb region of ALAS- The early
work of Granick in 1966 established that in chick embryo hepatocyte
cultures drug inducibility of hepatic ALAS activity is prevented by the
simultaneous administration of heme, The mechanism of this has remained a
central question ever since (Sassa and Nagai.
, 1996), It was originally
postulated that heme and drugs compete for a site on a gene-controlling
protein. This was challenged by the work of Srivastava et aI.
, (1980) who
showed that heme repression appeared to be the sole control and suggested
that drg induction was probably a secondary consequence of heme removal.
However, it was reported that drgs can directly increase murine and chick
ALAS- l mRA levels and gene expression (Hamilton et aI.
, 1988), and
DR4 and DR5 sites for nuclear receptors
, that mediate this induction
, have
been identified far upstream of the transcriptional start point (Fraser et aI.
2002; Fraser et aI. , 2003).
At the translational and post-translational levels , heme has been
shown to reduce ALAS- mRA stability (Drew and Ades 1989; Hamilton
et aI. , 1991; Cable et aI. , 1996; Cable at aI. , 2000) and prevent the entr of
newly synthesized ALAS- l into the mitochondrion (Kikuchi et aI.
, 1983).
However, with respect to the molecular mechanisms(s) for heme repression
156
of ALAS- l mRA (p. 7), controversy has persisted (Reviewed in May et aI.
1995), It has been variously shown that heme represses ALAS- l at the
translational level (decrease ofmRA stability) but not on the
transcriptional level (decrease of gene expression) (Hamilton et aI. , 1991)
and vice versa (Srivastava et aI. , 1988; Srivastava et ai , 1990; Ades 1990).
DeMena et aI. , 1999 , reported that in Schneider cells 30 IlM heme (for
24 h) repressed the luciferase activity of a 121 bp region in the 5' flanking
region of the Drosophila melanogaster housekeeping ALAS gene, In
contrast, effects of heme on ALAS- l mRA stability in CELCs and rat
hepatoma cells have been observed at a much lower concentration of heme
(1 IlM) (Hamilton et aI. , 1988; Cable et aI. , 2000).
Due to the complications associated with other mechanism(s) of heme
regulation, the studies reported here used ALAS- l promoter constrcts and
showed that Glut in combination with DHA, an inhibitor of heme synthesis
synergistically induced ALAS- I. The studies here also show that heme (20
IlM) repressed both basal and expression Glut- and DHA-mediated induction
of ALAS- l by one or more cis-acting elements in the - 3 to - 5 kb 5'
flanking region.
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These differences in results of this and other labs showing
transcriptional effects of heme on ALAS- l (DeMena et aI. , 1999) compared
to the studies showing heme effects on ALAS- l mRA stability and no
effects of heme on ALAS- l gene transcription in CELCs (Hamilton et aI.
1991) and rat hepatoma cells (Cable et aI. , 2000), require further elaboration.
Hamilton et ai, 1991 , measured the effects of 1 IlM heme and 0. 15 mM DFO
on ALAS- l gene transcription rate in chick embryo hepatocytes after
treatment for 1 h with 0. 14 mM 2-propyl- isopropylacetamide (PIA). They
observed no effects of heme or the inhibitor offerrochelatase, DFO , on the
PIA-induced increase in ALAS- l transcription rate. Cable et aI. , found
effects of 1.25 IlM heme on ALAS- l mRA stability starting at 1 hand
reaching a maximum at 6 h.
In this study, the drg, Glut, in combination with the inhibitor of heme
synthesis , DHA, synergistically upregulated ALAS-promoter-luciferase
activity and 20 IlM heme downegulated basal and Glut and DHA-induced
luciferase activity suggesting that heme (10- 20 IlM) regulates ALAS- l gene
transcription. The major differences between the transcriptional effects
observed in LMH cells and frit flies, and the studies showing effects on
t,"
"":,
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mRA stability is the time of treatment with inhibitors and heme (1-5h)
and/or the concentrations of heme (1 IlM vs. 10- 20 IlM).
Previous studies on the drg and DHA effects on ALAS- l enze
activity have suggested that prolonged (:;12 h) incubation with drugs and
DHA are required to obtain synergistic induction of ALAS- l enze
activity in CELCs (Russo et aI. , 1994), LMH cells (Kolluri et aI. , 1999) and
rat hepatoma cells (Cable et aI. , 2000). Another possibility is that the effects
of heme on ALAS- l mRA stability are seen at heme concentrations of 
IlM in CELCs (Hamilton et aI. , 1991) or 1.25 IlM in rat hepatoma cells
(Cable et aI. , 2000) while transcriptional effects of heme in intact rats
(Srivastava et aI. , 1988), LMH cell cultures (this study) and frit flies
(Demena et aI. , 1999) are obtained at higher heme concentrations (10-
IlM).
In humans , intravenous infusion of about 4 mg/kg body weight of
heme (approximate initial plasma concentration ~ 10 IlM) causes clinical
improvement and decreased excretion of heme pathway precursors , ALA
and PBG, in patients with acute intermttent porphyria (Bonkowsky et aI.
1971; Bonkovsky and Barnard 2000). After intravenous heme infusions the
initial plasma heme concentration that results in decreased ALAS- l activity
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in patients with porphyria is ~92- 1 08 IlM (Karl Anderson personal
communication). In this study, repressive effects on ALAS- l Luc-reporter
constructs are seen starting at 10 IlM with a maximal effect at 20 IlM heme
(Figure 5.4),
Inhibition by heme (40%) of the translocation of an in vitro translated
pre-ALAS- l protein into the mitochondron was observed in vitro starting at
concentrations of heme from 3 to 30 Il (Hayashi et aI. , 1983; Yamamoto et
aI. , 1983). These observations about the effects of time of incubation with
heme, and the concentrations of heme needed to produce effects on mRA
stability (Hamilton et aI. , 1991) vs. gene expression ((Srivastava et aI. , 1988)
and the results presented in this Chapter), taken together, suggest different
regulatory mechanisms of heme on ALAS- l mRA and gene expression
based upon the "free heme" concentration (or based on the extent of heme
pool depletion) in the liver cell. At low concentrations of heme effects on
ALAS- l mRNA stability (1 
IlM) and on ALAS- l translocation (3 IlM) into
the mitochondrion were observed in chicks (Hamilton et aI. , 1988; Hayashi
et aI. , 1983) while the effects on ALAS- l gene expression in this study in
LMH cells were observed at higher concentrations of heme (10 and 20 IlM).
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A 520 bp PCR product containing a 167 bp chick ALAS- l drg-
responsive element is capable of activating pGL3-SV 40 promoter constrct
15-30-fold in response to Glut (Figure 5, 10 B) but activates pGcALAS9.
Luc and pGcALASO, Luc only 3,2- and 3, fold respectively (Figures 5.11
Band 5.12 B). One interpretation for these results is that the +0,082 to 0,
kb region contains element(s) that contribute to non-heme mediated
repression of drg-induction (Figures 5.7 and 5. 8) (Kamei et aI. , 1996;
Dilworth and Chambion 2001; Akiyama et aI.
, 2003).
Conclusions: Thus the data presented in this Chapter demonstrate that
drgs increase ALAS- l gene expression (through non-DRE elements in the
+0,082 to - 5 kb region) and that high concentrations of heme down-
regulates basal and drg-induction of chick ALAS- l through ekment(s) in
the - 3 to - 5 kb 5 flanking region.
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CHAPTER VI
SUMMARY AND CONCLUSIONS
Studies of the heme bios thetic athwa : In Chapter III , studies of
the heme biosynthetic pathway and its regulation by chemicals and heme are
described in LMH cells and compared with primary chick embryo liver cells
(CELCs), LMH cells exhibited analogous responses to CELCs in terms of
inducibility of ALAS- l mRA and activity, in response to chemicals that
affect heme biosynthesis, LMH cells and primary cultures exhibited similar
increases in levels of ALAS- l mRA and activity after treatment with
chemicals that affect heme synthesis. Porphyrin accumulation and
overproduction were observed in response to treatment with chemicals that
are used in models of porphyria, A couple of minor differences were
observed in LMH cells in the amount of ALA needed to accumulate
porphyrins and the amount of protoporphyrin accumulated by treatment with
Glut and PB. Firstly, LMH cells required higher concentrations of ALA (300
IlM) than CELCs (100 IlM) to accumulate the same amount of porphyrin
(Figure 3,5). This may be related to differences in uptake of ALA into LMH
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cells , as previously shown for human hepatoma cells (Iwasa et aI.
, 1999), rat
hepatocytes (Sinclair et aI. , 1990) and ES cells (Harigae et aI. , 1998).
Secondly, LMH cells accumulated porphyrins (~ 1/2 was
protoporphyrin) to higher levels than CELCs in response to phenobarbital or
Glut alone and this accumulation was reduced by addition of 50 IlM FeNTA
(Figures 3.4 A and B). This is probably due the lower levels of iron being
available for conversion of protoporphyrinogen to heme in LMH cells vs.
CELCs. It is well known that actively replicating, growing cells require
more iron than non-replicating cells and LMH cells are consistently more
active in this regard (for recent review see Weinberg 2003).
LMH cells and CELCs displayed a marked up-regulation of ALAS
activity in response to Glut (50 
IlM) in combination with the inhibitor of
heme synthesis, DHA (250 1l) (Figures 3. 1 Band 3.2 B). LMH cells also
upregulated ALAS- l mRA after 6h of treatment with Glut alone or in
combination with DHA or FeNTA. Since LMH cells were treated with the
inhibitors of heme synthesis for only 6 h they did not significantly increase
ALAS- l mRA levels compared with Glut alone (Figure 3.3). This may
suggest that treatment for the given period of time (6 h) and/or the
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concentrations of chemicals used is not sufficient to see the effects of the
selected chemicals on the heme pool (Russo et aI. , 1994; Jover et aI. , 2000).
Because heme-dependent regulation of hepatic ALAS- l mRA is a
major component of the normal regulation of heme biosynthesis in many
species , a side-by-side comparison of ALAS- l mRA levels in LMH cells
vs, CELCs was performed. Heme-dependent repression of ALAS- l mRA
was observed for both cell tyes in the absence of any inducers (Figure 3,6).
In addition, as shown previously in CELCs (Russo et aI. , 1994), heme
decreased ALAS activity that has been increased by pretreatment with Glut
and DHA and Glut and FeNTA in LMH cells (Figure 3,7). These studies
supported the relevance of LMH cells as a useful model for further studying
hepatic heme biosynthesis and its regulation.
Studies on the Glucose effect: The critical biochemical abnormality of
the acute porphyrias is an uncontrolled up-regulation of ALAS- l in the liver.
In porphyric patients , ALAS- l is highly inducible, especially in liver, in
response to changes in nutritional status , and to many drugs that induce
cytochrome P-450 and/or affect heme synthesis, High intakes of glucose or
other metabolizable sugars and intravenous heme are the cornerstones of
therapy of acute attacks of these types of hepatic porphyrias (Bonkovsky
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1990; Sassa 2002). Both glucose and heme are known to repress the
uncontrolled over-expression of hepatic ALAS- l enzyme activity in the
acute porphyrias, although their molecular mechanisms of action have not
been fully characterized.
In Chapter IV, the glucose effect on ALAS- l was studied in LMH
cells using the combination of Glut and DHA as a model of acute porphyria,
In preliminary studies , glucose, in a dose-dependent manner, reduced the
Glut and DHA-induced ALAS activity in LMH cells (Figures 4,2 and 4,
and CELCs (Figure 4,5). Glucose was also shown in LMH cells to abrogate
ALAS activity induced by treatment with chemicals previously shown to up
regulate ALAS- l enzye activity such as Glut and FeNTA (Figure 4.4).
Further experiments investigating the dose-response with glucose were
completed in LMH cells.
To begin to define the molecular mechanism(s) of the glucose effect
further studies were done by transient transfections ofLMH cells with a
promoter-reporter constrct containing approximately 9. 1 kb of chick
ALAS- l 5' flanking region and 5'
- untranslated region (UTR) attached to a
luciferase reporter (pGcALAS9.1-Luc), Treatment for 16 h with Glut and
DHA produced a synergistic (5-fold) up-regulation of ALAS- l promoter-
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reporter activity in LMH cells transiently transfected with pGcALAS9.1-Luc
(Figure 4.6). Addition of glucose , in a dose-dependent manner, decreased
the Glut and DHA up-regulation ofpGcALAS9, Luc activity (Figure 4.6).
Other metabolizable sugars such as frctose , galactose, and intermediates of
glucose metabolism such as glycerol and lactate, but not the non-
metabolizable sugar sorbitol , also down-regulated the 9. 1 kb constrct
(Figure 4.8). A long lasting analog of cAMP , namely, 8-CPTcAMP
augmented Glut-induction ofpGcALAS9, Luc activity in a dose-dependent
manner (Figure 4,9). Thus , the "glucose effect" on chick ALAS- l is
dependent upon element(s) in the first 9. 1 kb of5' flanking region and 5'
UTR (- 067 to +0,082 kb). Some of this effect may be mediated by the
cAMP / CRE located at +0.039 kb (Figure 5,5). These effects were observed
in the absence of insulin, glucagon, other hormones or serum. Thus , the
glucose effect" on ALAS- l is not dependent upon effects of glucose
administration on pancreatic islet cells,
Drug and heme studies: ALAS- l is up regulated by chemicals that
also induce CYP (Jover et aI. , 1996). Some evidence has suggested that at
least two mechanisms of drug induction of ALAS- l exist, one that is by the
direct effect of the drg on ALAS- l gene expression (Hamilton et aI. , 1988;
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Fraser et aI. , 2002), and another that is mediated by its effect on the heme-
pool by induction of cytochrome P-450 apoproteins (heme-dependent)
(Sassa and Nagai , 1996; Kappas et aI. , 2000). However, there has been no
direct evidence for an effect of depletion of a regulatory heme-pool on
ALAS- l induction, and cis-acting promoter elements that mediate heme-
dependent repression of basal or drug-induced ALAS- l heretofore have not
been characterized, in mammals or birds.
In Chapter V, drg and heme studies using transfected (transient /
stable) parental ALAS 9, 1 kb and 3.5 kb deletion constrcts showed that
while the +82 to -3447 bp region mediates induction by drgs , the
3448 to -9067 bp region was responsible for heme-mediated repression of
drug induction in the absence ofDHA (Figures 5. 1 B and C), Neither heme
nor an inhibitor of de novo heme synthesis , DHA, had any effect on Glut
induction of the 3.5 kb constrct (Figure 2 A and B). In contrast, DHA
resulted in derepression of drg induction and a synergistic induction of the
1 kb constrct, which was decreased by the addition of exogenous heme
(Figures 5,3 A and B), Taken together these data suggest that distinct and
separate regions mediate regulation of ALAS- l by drugs and heme (Figures
3 A and B). In addition, these results indicate that element(s) in the -3448
167
to -9067 bp region mediate(s) heme-dependent repression of ALAS- l and
are supportive of the hypothesis that a regulatory heme pool (See Chapter I
p. 7) can influence the extent of drug induction of ALAS- I, A search of the
entire 9149 cALAS- l sequence (+82 to -9067) bp, including the heme
responsive region (-3448 to -9067 bp), using the MacVector analysis
software program and TRANSF AC Database (http//www,cbiI.upenn.edu),
for putative drg- and heme- responsive elements showed 5 consensus AP-
sites including an "expanded" Ap..l (Core B/ AP- l) located at - 1967 bp
(Figure 5,5), shown to be important for heme induction ofHO- 1 (Alam et
aI. , 1992; Alam et aI. , 1994; Shan et aI. , 2000; Shan et aI. , 2002). However
because the +82 to -3447 bp region (pGcALAS3. Luc constrct) did not
show heme-dependent repression (Figure 5.3 A), it suggests that the
CoreB/ AP- l at - 1967 is not involved in heme-repression of ALAS-
Deletions of the -9067 to -3448 region were generated and tested,
Transient and stable transfections of LMH cells with further deletions of the
heme responsive region, starting from the Xho I site (at -9067) to Pac I (-
7676) or Pm11 (-6266) (Appendix E), retained heme-dependent repression
suggesting that the -3448 to -6266 bp cALAS- l 5' flanking region is
involved in mediating heme repression. In addition, the promoter and
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proximal 5 flaning (+82 to -3448) drg-responsive region did not contain
recently defined DRE sequences that lie far upstream of the transcription
start site and have been shown to participate in the drug-mediated induction
of chick and murine ALAS- l (Fraser et aI. , 2002; Fraser et aI. , 2003).
Therefore, the +82 to -3447 bp region of ALAS- l is involved in non-DRE
mediated up regulation in response to drgs.
Studies on DRE: Basal expression of the ALAS- l gene is driven by a
number of specific transcription binding sites in the first 300 bp of promoter
sequence (Appendix E) such as CREB (Giono et ai , 2001) and NRF- l (Li et
aI. , 1999). The pGcALASO. Luc (+82 to -317 bp) constrct was tested in
LMH cells and basal activity ofluciferase was expressed. This constrct was
not upregulated by Glut nor repressed by heme and hence was used to help
delineate the heme-responsive region. To aid in this effort, DRE sequences
recently defined in the chick ALAS- l gene (Fraser et aI. , 2002) were
inserted upstream of the 0.3- and 9. kb constrcts and of the enhancerless
pGL3-SV 40 promoter constrct to generate the fusion constrcts
pGcALASO, Luc+DRE and pGcALAS9. Luc+DRE and pGL3-
SV 40+DRE, respectively, These were tested for drg inducibility and heme
repression. As shown previously (Fraser et aI. , 2002), the pGL3-SV 40+DRE
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constrct was induced many fold (~30-fold by Glut (500 1l) and 16-fold by
Glut (50 IlM)J, but interestingly, pGcALAS9, Luc and pGcALASO. Luc
were induced by 50 Il Glut only 3, fold (I.6 to 4. fold) and 3. fo1d
respectively (Figures 5. , 5.11 and 5.12 B).
Discussion of results with DRE constrcts: Although negative binding
elements have been described, repression is mainly conducted by
interference with other transcription factors (Saatcioglu et aI.
, 1994).
Transcriptional co activators, including the cAMP response element-binding
protein (CBP) and its strctural homolog p300 (Bannister and Kouzarides
1996) not only link transcriptional activators to the transcription machinery
but also have been found to possess intrinsic histone acetyltransferase
activity that is required for transcription factor fuction (Kamei et aI. , 1996;
Perissi et aI. , 1999; Dilworth and Chambion 2001), Recent evidence
indicates that the coactivator CBP and its strctural homolog p300 are
important for nuclear receptor fuction (Dilworth and Chambon
, 200 I ;
Chakravarti et aI. , 1996) including CXR mediated induction of the CYP2H 
gene (Dogra et aI. , 2003), CBP is also essential for CREB regulation of basal
and cAMP-stimulated expression of ALAS- l (Guberman et aI. , 2003).
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The present finding that drg induction from the DRE constrct
(pGcALASO.3Luc+DRE) is repressed by element(s) in the +82 to -317 bp
region of ALAS- l (Figure 5.12 A and B) is in keeping with the notion that
competition for limiting amounts of the coactivator CBP/p300 in cells can
result in inhibition of gene activation by transcription activators (Kamei et
aI. , 1996; Dogra et aI. , 2003; Guberman et aI. , 2003).
These DRE studies suggest that, as seen before for the 7.6 kb
constrct of ALAS- , the - 3 to +0.082 kb 5' flanking and 5' UTR region
contains element( s) that negatively regulate ALAS- l induction by drugs as
seen previously (Saatcioglu et aI. , 1994; Dilworth and Chambion, 2001;
Dogra et aI. , 2003).
Conclusions: Drugs up-regulate ALAS- l mRA and activity in LMH
cells as shown previously in CELCs, This up-regulation is mediated through
transcriptional effects of the drgs on non-DRE and DRE-elements in the 5'
flanking region of ALAS- I. Heme and glucose down-regulate ALAS-
transcription through element(s) in the 5' flanking region and therefore in
their presence induction of ALAS- l is decreased as seen before in patients
with porphyria,
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Future Directions
Further characterization of the repressive effect of heme on ALAS-
constrcts: One promising line of experiments is to identify heme-
responsive element(s) in the -3445 to -6266 bp region and factor(s) that
regulate ALAS- l promoter expression and that are influenced by heme.
Because conveniently located restrction sites are limited in this region, PCR
amplification of this region using a high fidelity polymerase
, such as Pfu
DNA polymerase, and specific primers should be used to generate several
smaller deletions of this region. The PCR products can then be amplified
using a second set of primers containing Xho 1 sites as described in Chapter
II for generating the DRE constrcts. Following the methods outlined in
Chapter II these products can be digested with Xhol and inserted
downstream (as described in Chapter III) of the DRE (which has been
inserted in the Mlu 1 site of the multiple-cloning site) of the
pGL3SV 40+DRE-constrct, shown in these studies and by Fraser et aI.
2002 , to increase luciferase activity ~30-40-fold in response to Glut (500
IlM) (Figure 5. 10 B),
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LMH cells transfected with these constrcts can be then treated with
heme or DHA alone or in the presence of Glut to delineate the heme
responsive region. In light of the studies presented in Chapter V that heme
can repress drg-induction of ALAS- , using the pGL3SV40+DRE
constrct containing the putative heme responsive region(s) should increase
the sensitivity and facilitate easy identification of the key region(s). Once an
~ 100-50 bp region is identified, it can be analyzed using electrophoretic
mobility shift assays and site-directed mutagenesis of candidate regulatory
elements in this region with the goal of functional characterization of the
heme responsive element(s), Such studies will lead to the ultimate goal of
identifying proteins and molecular mechanism(s) that play key roles in
heme-dependent regulation of ALAS-
Determnation of the cis-acting element(s) that determne mRA
stability (identification of 3' -UTR elements in the ALAS- l mRA) and
those that mediate heme responsiveness in the 5' -flanking region of the
ALAS- l gene wil shed more light into the question of how heme regulates
ALAS- I. The data from this dissertation, that heme can regulate cis-acting
element( s) in the 5' flanking region of ALAS- l and from studies of others
demonstrating that heme decreases ALAS- I mRA stability and gene
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transcription, as discussed in Chapter V
, suggest different regulatory
mechanisms at different heme levels in the cells. Of particular interest will
be studies to determne the heme concentrations and time of treatment with
heme or inhibitors of heme synthesis required for heme effects on
transcription vs. stability.
The data presented in this dissertation also suggest that glucose and
heme can regulate cis-acting element(s) in the 5' flanking region of ALAS-
as has been seen with ALAS- l enzye activity in patients with acute
porphyric attacks, Further studies looking into the signaling pathway(s) and
component(s) of the pathways that mediate the effects of "glucose" and
heme will be of significance in acute porphyria, Of particular interest will be
potential cross-talk between the signaling pathways,
(4)
(5)
(6)
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APPENDIX A: MEDIA AND BUFFERS
Media Contents
Waymouth' s MB 752/1
Medium, powder
Component
Amino Acids:
L-alanine
L-arginine
L-arginine,HCl
L-asparagine.
L-aspartic acid
L-cysteine
L-cysteine,2HCl
L-cysteine.HCl.Hz
L-cystine.2HCl
glutamic acid
glutamine
Glycine
histidine
histidine.HCl,
isoleucine
leucine
lysine,HCl
L-methionine
phenylalanine
proline
L-serineL- threonine trtophan 
tyosine.2Na.2HzO 57.L-valine 
Williams ' E
Medium, powder
(mg/L) (mg/L)
40 
100.
150
350
26,
292
164,
240 87.46
50,
200
Inorganic salts:
Caclz 90. 200
CuS04. 0001
Fe(N0 )3.9 Hz 0001
KCl 150 400
MgClz 112.
MgS0 97, 97.
MnClz.4H 0001
NaCI 6000 6800
HP0 300
HP0 140
ZnS04. 0002
Other Components
glucose 5000 2000
Glutathione (reduced)
Hypoxanthine.
Methyllinoleate
Phenol red
Sodium pyrvate
Vitamins
Ascorbic acid 17,
Biotin
Ca pantothenate
Choline chloride 250 1.5
Ergocalciferol
Folic acid 0.4
inositol
Menadione sodium
Niacinamide bisulphate
Pyridoxine.HCl
Riboflavin
a- Tocopherol phosphate
, -
sodium salt
Thiamine- HCl
Vitamin A acetate
Vitamin B 0.2
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Willams ' E Special Medium without glucose or sodium pyruvate
contained all of the above except 2000 mg/L glucose and 25 mg/L sodium
pyrvate.
Williams ' E Regular medium was supplemented with:
5 IlM 3 triiodo- thyronine
76 M dexamethasone
200 Il glutamine
Waymouth' s MB 752/1 Complete Medium was supplemented with:
100 U/mL penicillin
100 Ilg/mL streptomycin
10% (v/v) fetal bovine serum (GIBCO)
OptiMEMCI Reduced Serum Media was purchased as a liquid from Life
Technologies, Inc. No modification or supplementation was made.
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Buffers
Phosphate Buffered Saline (PBS):
100 mM KPi
15 M KCl
Adjust to pH 7.4
lOX HEPES Buffer:
200 mM HEPES
50 mM sodium acetate
10 mM EDTA
Adjust pH to 7,2 with NaOH
Filter to sterilize
20X SSC:
0 M NaCI
3 M sodium citrate
Adjust pH to 7.0 with 10 N NaOH
Autoclave to sterilize
Harvest and Assay Stock Buffer (ALAS Activity assays):
35 mM Tris
30 mM NaH
8 mM MgCh
1 mMEDTA
15 mM succinate (disodium salt, 6 H
10 mM sodium laevulinate
Adjust pH to 7.4 with HCl and add
5 mM pyridoxal- phosphate
Stable for 1 month at 4
, Working Reagent: To 25 mL add just before using:
10mMATP
1 mM CoEnzye A
5 mM -mercaptoethanol
100 mM KF.
12.5U succinic thiokinase
Modified Ehrlich' s Solution:
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Glacial acetic acid 168 mL
70 % Perchloric acid 32 mL
Mercuric chloride 0.75 g
Add 200 mg of p-dimethylaminobenzaldehyde (DMAB)/10 mL
Ehrlich' s reagent just before using.
TE Buffer:
10 mM Tris. , pH 7.5 or 8,
1 mM EDT A, pH 8,
Z Buffer ((3-galactosidase assays):
60 mM Na HP0
40 mM NaHzP04,
10 mM KCl
1 mM MgS0
Adjust pH to 7.0; store at room temperature
ONPG (O-nitrophenylgalactoside):
4 or 5 mg/mL in 0. 1 M potassium phosphate , pH 7,
Filter and freeze.
Glycylglycine Harvest Buffer (Luciferase assays):
25 mM glycylglycine, pH 7.
15 mM potassium phosphate, pH 7,
15 mM MgS0
4mMEGTA
1 mM DTT (added just prior to use)
Bicinchoninic Acid Protein Assay Stock Reagents:
Reagent A (0.125% BCA): To 950 mL MQ add
161 mM Na
67 mM sodium potassium tartrate
113 mM NaHC0
75 mM NaOH
63 mM bicinchoninic acid
Adjust pH to 11.25 with NaOH
, QC to 1000 mL
store at room temperature.
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Reagent B:
160 mM cupric sulphate. Store at room temperature.
Working Reagent:
Mix 100 volumes of stock Reagent A with 2 volumes of stock
Reagent B. Stable for 1 week.
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APPENDIX C: LIST OF PLASMIDS
NAME OF PLASMID CONTAINS: REFERENCE or
SOURCE:
pBLUESCRIPT KS II+ DNA filler in Commercial
transfections
pPGK/ gal galactosidase w/PGK Paul Dobner
promoter
pGL3-Basic Luciferase vector wino Promega
romoter or enhancer
pGL3-Control Luciferase vector Promega
w/SV40 promoter and
enhancer
pGL3- Promoter Luciferase vector Promega
w/SV40 romoter
pGcALASO , 3 - Luc ALAS- l/1uciferase Sridevi Kolluri
re orter gene
pGcALASO. Luc+DRE ALAS- l/luciferase Sridevi Kolluri
(native orientation) reporter gene
pGcALASO. Luc+DRE ALAS- l/luciferase Sridevi Kolluri
(reverse orientation re orter gene
pGcALAS3, Luc ALAS- l/luciferase Timothy J, Sadlon
reporter gene
pGcALAS4. Luc ALAS- l/luciferase Sridevi Kolluri
re orter gene
pGcALAS6. Luc ALAS- l/1uciferase Sridevi Kolluri
reporter gene
pGcALAS8. Luc ALAS- l/1uciferase Sridevi Kolluri
reporter gene
pGcALAS9. Luc ALAS- l/1uciferase Timothy J. Sadlon
re orter gene
pGcALAS9. mCREB ALAS- l/1uciferase Timothy J. Sadlon
reporter gene
pGcALAS9 . Luc+DRE ALAS- l/luciferase Sridevi Kolluri
(native orientation) re orter gene
pGcALAS9. Luc+DRE ALAS- l/luciferase Sridevi Kolluri
reverse orientation) reporter gene
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APPENDIX D: STRUCTURES OF CYP INDUCING CHEMICALS
C =CH
)HCONH
(H( CH3
Allyl isopropyl acetamide Dexamethasone
CH 
RU486 PCN
. N 
. ,
CH3
'I 
Phenobarbital Glutethimide
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APPENDIX E:
SEQUENCE OF ALAS- PROMOTER AND FLANKING
REGION
In the following sequence the restrction cut sites are shown by ~ ~ ~
swiggly lines, Sites that define the end of a reporter constrct (shown in
Figure 5. 6) are indicated in bold tye followed by constrct length in kb in
parenthesis. The ends of forward and reverse primers used during
amplification with Pfu DNA polymerase are underlined, All putative
transcription factor sites (eg. Core B AP- and CREB sites) are bold
underlined, The TAT A box is shown in bold tye and italicized. Bold
nucleotide indicates G subs by T to *create pGcALASO.3 Hind III site.
Numbering of bases is in reference to the transcription start site = + 
XhoI(9.
------
9107 9067 CTCGAGATGA
9057 GCTAACCAA GCTGAGCAGA CAAGCAATGT GCTCACGCAA CAGAGCTGCA
- 9007 CAGAGCCCCA GACCGTGCCA AGTGCTGCCA GCTAGCAGCC CAAGGGCCAC
8957 CCAGCCTTGT CTCTCATCCA GTCCAACACC AGATGCTTCC CATGTAGGTG
-8907 CAAGAGCCCC ATCCTGCCTG CTGGGGTTTA AGAAGCAGGG TTAAGGCACC
8857 CCATCTCATG AACTGATGG CCTCTCCAAC TGCTGGTGGT GATGAGCTGG
8807 ACATAAGTAA GCTCAGCTTT GCGGTGGTTA AACTGATTTG TTTCACAGCC
8757 AGCCATCCTT TTGTTAGGTT CTCTCCTATT GTGGAACAA GCCCCAGAGA
8707 GGCTGGAGAT GCTGGGAACA GGAGGTTCTC CCCAGCTGCC ATACAGTGGG
8657 CAGCTCTCTG TGGCCACCAA TTGTGCCAGA AGCACCGCCG TGCCCTGTGG
8607 CACAGTGCAT TTGAAGCCTG CTTTGAATA AACCAAGA AGAGTTAA
8557 ACAGGGCAGC CTTGCTAAGG TCTGCTTGAT TCACCCCTGC TGTCGTATTG
AP-
8507 AATGCTGCCG GAGGATTGCT CCATGCAGGG AACAATGCAG AAGCCTGG
8457 ATGAGGAAG CCTCGTGACG AGGAAGGCTC ATCTGCTTCC CTTCAGAGCA
8407 GCTGCACCCT GCCAAGGACA GATGCGCTGG GCACGTTTGT GGGGATGGCT
8357 CATACATCAT AATGAGCAA CTCATTCAAT AACCACACGT TGGTGAGGCA
8307 GTTTCTAATC GAAGCCTTCC TCCGAGCAA GATAACGGCG GCCCTCCCTG
-8257 TTCTCACCAT GGGTACGTGA CAGTGCCCGG CCATCCACAC GGTGCTGAGC
8207 CGACGTGACA GCCCCAGGGT GCCCTGCCCG TCCCCTGTCT GACTGCACAG
-8157 ATCTTGCACG AGTGAGACTT CTCAGCTGTG TGGGAAGCAC ACTGCATGGC
210
8107 GGTGCCCACG CTTCCCCAAG CAAGAAGCAG CCGGGGCACA GGGCATCTCC
-8057 AGGCCTGCTG ATATGTAGGG GGTTTGGGAA AGAAGAGAGG ATAGTGAGGG
-8007 GTATTAAGGG TTGTTGCAAC AGAGGCAAC ATGAGTGAAG CTGGACTTCA
-7957 CTCCTCCAAG CCCCACAGCC ATCTGCCCTG GCTGTAGGTG GCAGCTTACA
7907 CCAAGGGCCT CCTCTCCTCT CTGTGGGTAT CACACAGCGT CAGCTCTGCT
-7857 GTGTGCGAAG CAGAGCAGCC CCAGACTAAC TGCCCCAGCA CGGTGCTGGG
7807 A TCAGCTCTG GTTTGGGTCC CA TTGGCACC CGAGGCTTTT TCTTGTTCCG
-7757 CATCCCCTTT TCACCCTGGT GGGACCATCC CATCTCCCAG CACGGGCTGC
PmlI (7.
-------
-7707 TCCCCAGCTC AGGACTCTGC CACGCAGGCA CGTGGCTGGC AGGACAGACC
-7657 TAATTACCAA AACCAAGCTC ATTAAGAC AATAAGCCCA GACCGCTAGT
7607 AGACTTGAGA CCTGCTGTCT GCCTCCATGC ACCA TTCCCC CACCCCAGGG
7557 TACACCAAC CCTGGGCTGT CTGCCCACTC GCAGGGCAGC ACACGTCCCT
7507 CCTCCATCCT CCTGGGCAGA GCAGTGGAGA AGGGAAGC CAGGCTGCCT
7457 GCCACAGCTC TCCATGCTTT CCAGAAGAC CTGCTCAGCA GAGGAGCCCT
-7407 GCTAGAATTC TCCTACTCCT GAACTGCTT TCTTCCTTCC AGCTGGTGAT
7357 GACCTACATA ATAAGCAGGT CACTGGAACA TGAGAGGGTT TTTTTGTGAG
7307 GCAGAGAAGA AAGGCCAAGC AATTCCCCCA CTGTGCTTGC TTCCGAGGAC
7257 AAGCGAAGT GCTGCTTCCC AGGGGTCTCA TTCAGCCTGA CAGTCAGCTC
-7207 TTCCCATCTG AAGCAGTGG GAGCTGCTGG GATCCCACCG GGGAGGCCAT
7157 TGGACCCTGC ATGGAGCATC AGGCTGCTTG AGGACCGGCT CCATAGGGGG
7107 AGGATGAGGA GAGCCTCGGG GAGCACGAGC CCTCCTCGCA TGAGCAGCAA
7057 ATGTGCCATG AGCAGCCCTA TGCACACGGC TGGGAACCCA CACTGCATGT
AP-
7007 GATTCAATCT GCTGCACATG GCGAGCTCTC ATCAGTCTGA AGGGAGGGAA
6957 GGAGAGAGCA GGAGAATGTG GAGGAGACGA GGCCCCACCA TGGGGCAACC
6907 CATGCCCAGC TGAAGGAAGG GA TTTGCTTT AGCAACCTC TGAGTTATTC
6857 CCATCTGGGA CAGCACTCTG CCTGAATC TGGCAGGTAA CAAGGGGTT
6807 AGCAGAGCCT GACTTTCTCA GTCTCTAGGC AGTTCTGCTC CTTTGCTCCT
- 6757 AAGGCTTGC TGCAGTGATG CACAAGCCA GAATGAGAA GGAACCGAG
- 67 0 7 TAGCCCCGAG AGATGGAA CCTTGGGAGC CCCCTTCAGC AACAGCATGG
6657 TTTAGGATCT GGTAGCAAG AACTGGATGG TCCTGAGCCA TTTTTCACAC
6607 CCCTTCCCCC TATCTTGCAG CTGATCTATG CCCACCCTCA GCTCCCTGCT
6557 CCCACATGAA GACAACACTA GGAAGATGT AGGCCAGCAG CTCTGATCCC
211
- 6507 CATAGCTGGT GCACCACAGG CAAGAAGCTT GCAGTTACCC ACCCGAGGGT
6457 AAGTGAGGA TCTATTAGGG AATGGATGT AATGGGAGCC CAGCTGGGGC
6407 TCAGCACAGT GCTGTCAGGG TGCACAGAGC CAGTAACCAG AGCAGAGCAG
-6357 GGGAAGAAGC TCTATCAAGC AGGCTGGCAG CTTGGGGAGC TCCAGTACCA
PacI (6.
---------
- 6307 CTAGCACCAG CTCGGTAAGT AGGTCACAGT TATGATCCTT AATTAATCCT
6257 GAAGAGACCC CCATCTGCCA TGGGGAAGAT GACAGATAAG GCAGCTCATT
- 6207 AAGCCAACGG GCAGGCAGAG GGAATGCCAC AGCCCAGCCT AACCCCTACA
6157 GATAGCAGGA CAATCCTGC TCGGTGGCAG TGGCTGCTCT GCCCAGCCTG
Ball
-------
- 6107 CTCCTGGCCA ACAGGTGCTC CAGGCTGTCC CTGTCCCCTG CGAGGAAGCC
-6057 CCACCTAAC CATAGCAGTG TAAGCCTGTC ACAAGGGAGA ATCTGAAGCA
6007 AAGCCAGCCC AGGGGCAGGC AGAGCTGGGC TCCAACAGGG GAGCCATACA
5957 GAGTCTCGAA CCCCAACCAC CTGTGCAGTG CTTACCCTGA GCCCAGCCCT
5907 CCCCACGCCT CCTGGTGCTG CAGGCAGCCA ACATCAGCAG GGACAGCAA
5857 ACCGGGCAGG GCTTCAGAGG ACTCACGCGG AGCAGGAACA TTAATAG
-5807 TGCTCTGAAG GGAGGGATGT GTGACTAACA AGCCCCACGC TGGCAATGGT
AP-
5757 GGTAGATGGG GGCAGCTTAG TACCAAGCC ACATCTGCAG AAGCCCTTAT
-5707 TAAGGTGTCA CTTGTGCTTG CTGCCACCCC CAGAGGCATT GTGTTCAGCA
5657 TTGTGCACAA CTGACAGCGT GCCAGAGCTC AGATGGAGCT GCATATGATT
5607 CAACCCGAAC AAGGAGCAAG CAGAAGCT GCCAATAGA CATCAACAG
5557 TATTTCTACC CAAGAACT CCGACTAGCA GAGGAACTGA GCCCCAGCCC
-5507 TATGCATCAC CACTCTGCTG TGCGTTGTTC CCCTGACCCA AGTGCAGCTG
5457 GGTGAGGGGC TGCAGTGCCA CAAGGTTGGT CCATGAAC CAGGTCACTG
-5407 GCTAACAAGC CCAGGAGATA GTGCTAGGGC TTTGGGAAGT ATGCACTGAA
-5357 ATCACTTCTT CCAATTAAGA CACAAGCTTA GAAGCAGTT CTGGCTTATT
5307 TCCTCTTGTA ATCGGAGCTT TAATCTCAA TTACTTGCTC AAGCTCAT
5257 CATCCTTCGT GGTAATACA TCTTGGCAGA GAGGTTGCTG TGAAGGAGAT
5207 GCGGTTTTGG GAACCAAGCT GAAGGAACC CGAAGGTCA TCACTTTTTG
5157 GAGGCAGCAG TGCAGACAGC ACAGGCAGTA TGGGGCGAGC TACAATCCCA
5107 AGGGCTCACG GGGGAACCCA GAGCTCATCC CCTCTCCCTC CCAGCAGTTC
-5057 AGCAGCACGC TCCTTTGCTG TGTCTTCTCC TTGTCCCACC AGCCAAGTG
212
5007 CAA TTCCAGG TGCTGTGCCA GCTCTGAAGA CCTTCTGGAC ACCAACGCAA
-4957 GACAGCATAG GGATCCAGAG GGTTGGCTCC ACTTTGCGTG TTAGAGCTGG
-4907 TGGCTCCAGC TTCATGGCTG ATGCCAGGGC TGATTGGCGA TCACCTCTCC
4857 ACTTGTTAAG GAATGGAATG GAATAGAATG GGTTTCCGTT GGAATAAC
4807 TATAAGACC ATCGATTCCA ACTACCAGAC TCCTGCCCAA AGCTGAACA
-4757 TACCATTAAG AGCATTATCC AATTATCCT CTTAACATG GACAGGCGTG
-4707 AAGCA TCAAC CGCCTCCCT A TGAAGCCTTT TCCAGTGACT GATTACCTTC
4657 TCAATAAGA ATTTTTCCTA GTATCCACTC ATCACGATCC TAATATCCAC
-4607 TAACAGGCAC CACTTCAGCC CTAGCATCCC AGCAATAGCA ATGTGCCTTT
BstEII (4.
---- ---
4557 TGTTAGTGCT GCTGTTGTCT GGAGAGGGTC GGTTACCTGT CACCCCAAT
-4507 ATCCCCCCAT GTAGAGGCAT CACCCCTCCC CACTATATTC TCCCATGGCT
-4457 CGGTCCCTTC TCCCTGTTTG AGCCAGGAGA GAAGCTTAA CCAAGGGGTC
4407 AGCCTTTATC AGTGCTGAGC GGGGCGTCTC AGGAGGGATA TTAATATAC
-4357 AGATATATAA CCAAGCACGT CGTTAATTT CACACTAGGG ACAGGTTGCA
-4307 ACATTTTAAG AACATGAACT CCAATGGTG GGGTTCTTTA GGTTCAACTT
-4257 TGAAGCACAG ACTTGCCAAG ATCAGAAGTC TTTAAGTCA CACCACATCA
4207 CAGCCATTGC TCTACGAGGA GCCTGTGGGA TGGCAGCA TG AATCCTTGGG
4157 CAATGAC TGCAAGTCCA AAGAGAATAG ATTTTCTGAT GTATGTAA
-4107 GCTCCCTGGG ATAACAGGG TTCTATGTGA AACCACAGCA CAATGTTGA
4057 TTAATGATC CGTAGCAAG CCAGCAGCAC ACATAACTCC CCAGCCTCCC
-4007 TTGGTTTTCC CCTACAATCA TTTCAGCATG GGAATTGGA CGTGAAGTA
3957 AAGAGAATGA ATTAAGTGTG TTTTGA TTTT TGCCATTTCA TAGCTGGTGC
3907 CTTTCCGCTT CTTTGTTGCA CAACGTTTGC ACTTCCAGCT CTTTCGAGGA
-3857 GGTTTCCTAG AATCAGCTTT TCTCTTCCCT CGCCCAGGGC TGGAGCAATG
3807 GATAGTTACA AGAGAACCA CA TGCA TCTC ACCCCAAGAA GTGGAGCAGT
3757 TCCTGAAGA AGACATTCAA GACTCCAACC GTCACCACCA CCACCAAGCC
3707 AACACCCAAC AGGGCTTGGT TTGCTCAGCA CAGCAAGCCA GAGACTTCAA
3657 AAGCTTGCTC CTCCAAGCCC TTTAACGCCA CAGATCCCAG CTGGAATGGA
3607 GCTCGAACCT CCCAAGCC ATCAGGTCAA ACAAGCTGCA CGCAGAAG
3557 GTTGGCTGGG TCACGGTACC CCATGAACC TCCCATCCCC AGCTCTCCTG
3507 GCTGCTGCTC ACTGGTACTG CTCCCAGTCT GAACGCTGCC ACCTGGCAGG
SmaI (3.
-------
213
-3457 CAGACTGGCC CGGGAGCCTT GGAAGCAGAG CCCAGTGCTT TGCGTGACTA
Ball
------
-3407 AGCTTGTTTG TAAGATAGTG CAACAGAGC GTTGGCCAGC TTTTTGATGA
3357 GCTCGGTACA AAGGCAACG AGGAGTGGAA GCTTCGTGCA CTCCGATAAC
-3307 CTGAATATAT TGCACGGCTT CTTGGGATTG CAGCTCACAA TTTGGAGATA
-3257 CGATAATTTC CTTCCTTCTC CCTTCAGTGC TGGCTCCTTC TCCCCTATTG
3207 CCGACATTCT TCTCGTTTTA ATACCCTATC AATGTCTTCT AACCTATCTG
-3157 TCATCTTTAG AGGAAGAATA AGTATTGCAC CCCAAGTTT AAGCAACCAG
-3107 AGGTATTGCA AAGAGCAGAG CAAGCCCCGT GGGCAGGAGG AACTTACACT
3057 CACATTGGGA GATGGACAGG TTTGGATAAG AAGCATGA GCCAACAATA
-3007 AGTAGCCTGG CAGGTAGGTG TGCTGCACCA CTTCAAGGTG ACAGCCCTTT
2957 TAACCACAT CATTTCTGTC TGCCCAAG ACGCCCTGGG ATGTCATCCA
2907 TGTCAGAGAG GTGATGCATA TGGGATGAGG AGGACAGAAC ACGGCGCGTC
2857 CTCGA TTGCC AGCAACCTTC TGTTTGAAGC CTTCACATTG ACATCGCTTT
2807 AAGGAGACA GCCCCAAGC CCCATCGGGG CATTTCCATT AGTGTGTACT
2757 GATTTCTTGT TTTCAAGGAC CTTTCCCAGG TCCCAGCTCT GCTCTGACAT
2707 CCACCTTCAT GCCAATGCCC ACACTAATGC AGGTGCAAGC AGTGACTGTA
2657 GCTCACTAGG GCTGCACGGT GTAGCAAGA TGCTCCACTA TGCAAGCACG
2607 ACTTGAGCGT CTCCCATCAG ATACAGAAGT CGCACACACC TTTCTCTCCT
-2557 CTACCAACCA TCCTTCCAA T GGAACCCAG GTTGCAGAGA GCTGGAGAAG
2507 GCTGTGACTT CAGAGCAAG GCTTTTCCCT GCCCTCTCGC CTCCGTCCTT
2457 CCTTCCCAGC CCCTGACACA AGGAGTGCTT GGAGGGAAGT GAGATTTCCT
-2407 CTTCTGCCAT GTGAGAAGCG CACGGAGAGC ACTGGATCCA AATGGGGAA
2357 ATCTGCTGAA GAATTCAGCA CGGGAGGAAT TTTTGCTATG CAGCTCTCTC
-2307 CCAACCCTTG AATTTTGCCT TTTAAGGTAA AGTAAGTTCT CTAAGAATG
-2257 CTCGTTCTCA GCACTGGAGG TGGAATTCCC AGCTCTGAGC CTGGAATTTG
2207 AGTCTGGATT TAATCCAGAT GTCAAGATCA CATCCACTCC CTTAGAAT
2157 TCAGATCTCA ACATAGAGCG TGGCTTGTGC GTGGGGAGGG GGTTGTTTTT
2107 CTGGCTTGCC CTCTCATGAT ACCGACTGGG TGGGAAG GAAGGAATGT
2057 GCACAGCTCT GGGTGGAGAA GTGGGAGAA GGGA TCCAGT GCTGCTAGAG
2007 GTACAGTTAT ACACTTCGGA TCGCACAGGC TGAGTCAGAG AGGCTTCAGC
(CoreB/AP-l)
-1957 TCTTGCTTTT CTCACGATCT AATGATCCC TAACAGCAC AACCCATTA
1907 GAA TTCTCAG AAGGACTGTC TGCTGACAGA TGTGGGACTG GGCGAAGGAA
r.j
214
-1857 AGGTCTCCGC ATCAATGTT GCTTATGGGA ATTCTGGGGA AACTTGCTCA
-1807 ACGAATGAGA GATAGGAGGG AAGTACCGAA GCTAACTTCC ACCTGAGCCT
1757 GTTTGGTAA GCAGCAGCAC GGAAGGGAAC GTCTTCCACA GCAGCTCTTC
-1707 ATGGACAGCT GCAGAATCA GTCTCCCATC TCCAGCCACC CCCCAGGGCA
-1657 GGCTATGGAA GCTCTCTGTT CTCCATCCAG CCCAAGTG CTGTCCCAGA
-1607 CTCCTCTTTC TGGAGCACGG CAAGGGAGG TTGTGTGGCA ATCCAAGCAA
-1557 GCTTTTGCTT AGCCCTGTAG GGTGATAGTA A TGCACTGCC ACAATTAAC
-1507 ACCACGTAAC TAATCCCTTG AAGCCCTAAG AAGTCTTAGT TAATGGCAGC
1457 TTTATTAGTA TTCGCTTCAC TTTCGACACG TAAGGTCTGG CAATGAGGGC
-1407 AGTGCTGCAA AGACACCCTT TCCCTTTTCC ACTGCATTTA CCCCCGTTTT
1357 GTTGGCCCTG GAGCTCAA TAATCTCCGT GCACTGACAA GGACACATTC
-1307 CTTCAGCAGC TCTCCAAGAC AGGGGTCAAG TTCATGTCAT TCCA TTGCCG
-1257 TTTAGCTCTG CGCAACTCCT GCCTCGTACA AGGTTAAGA AATACGCCAA
-1207 AACCAAGCTC TAAGAAGGG CTACAATCAC ATCTGATTAA CAGCACAGAT
1157 TACAAGGGAG CCTGACAGCA AAGCTGAGAG CTCTGCTTCA CTGGGAGACC
-1107 TCTGTGCCAT AGCCAAGGTT GCTGCCTCAG CTTCCAACCT TGAATCAAGT
AP-
-1057 TCGAGTAGAA CATGGATGCT CTCCAGGCTT CAACTCTTG AATACAACC
1007 CAAGAGCTTC TGAATTCCGG CAGCAGAGCA GACTAACAAC ACTTCATCCC
-957 TCGACCTTGC AACACACCGA GGTGCTGCTA TTAAGATAAG AAGGATAAG
907 CAGCATGATC CGATTGTTGT GGGATTGAAC CTGCTGCGGC AGGTGTCCGT
-857 GGGGATGAGC TCTGTGTAAC ACAACCCCCT GGGGGGTGGG GAAGGCACAG
807 ACAGCAGGCA GCCCAGCTCT GCCTTCTGCC AAGGTTTTGC AATATGGGGA
757 AGGAACGCAT CACTGCCCTT CTCCTCCCAC GCCTCAGCAG TCGGCGTATC
707 CCCTGCAGCA ACAGCACCGG GATGGCCGCA TCTACGCTGA GCTCCTTCTC
-657 TCA TCACCAC CTGTAAGCAG CCTTTGATAA AATCCCTGA TGTTAACGCT
607 CACTGCAAC CAGGGGTACA AATCACAGTA CTGCAGGGCC ACTTTCACAT
557 CAGGGCTCCT CATAGGATCA CAGAATGGCC TGGGTTGAA AGGACCACAG
507 TGCTCATCCA CTTCCAACCC CCTGCTATGT GCAGGGTCGC CAACCAACCA
-457 GCAGCCCAGG CTGCCCAGAG CCACATCCAG CCTGGCCTTG AATGCCTGCA
407 GGGATGGGGC ATCCACAGCC TCCTTGGGCA ACCTGTTCAG TGCGTCACCA
TRE
357 CCCTCTGGGT GAATCAT CTCCAACC AGCGGCACCA CAACTGCGGA
307 ATGAGAAGCT GTGAGATTTG TGCTGGCTGG AGGCAAGCG TGAGGGCCGG
*Hind III (0.
257
207
-157
107
-07
+44
215
AflII
-------
GATCCTTAAG CCACCAGGCA GAACTGTGTT AGTGCATCCC CAGGGCCCCC
SmaI
------
TCATGGCCCC TCATGGTCCC CCCATGGTCC CCTCAGAGCC CCCGGGGCCC
CTCACCACCA CTGGGACCAA TCACGGCTCG GAGCGCAGCA CAAGCCCCGC
CCACTCCATC ACGCCACGCC TCCTCGGGGG CGGAGCATAA ATTACCCTCA
Not I
---
GTGCGCCTGC GCGGAGCCGG CAGGGCTATA TAAGGGCGGC GGCCGCGAGT
TATA BOX
CGGGGCGCTG TTCGCTTTCC GCCCGCCGTG GGGGTGACAG CTGCGTGACG
HindIII CREB
-----
TCACTTCCGG TCGGCGGTAG CTGCGGCAGG AGGAAGCTT + 8 
216
SEQUENCE OF DRE (522 bp) IN ALAS-1 5' FLANKING REGION
(13792 to 13270)
In the following sequence the restrction cut sites and forward and reverse
primers are shown by ~ ~ ~ swiggly lines. Mlul sites added to the ALAS-
sequence (522+16 bp=538bp) are shown in bold italics. Forward and reverse
primers used during amplification with Pfu DNA polymerase are shown by
~ ~ ~ swiggly lines and designated PRM. Transcription factor sites (eg.
DR4- and DR4- sites for nuclear receptors) shown to mediate drug-
induction of the chick ALAS- l gene (Fraser et aI. , 2002) are bold
underlined. Numbering of bases is in reference to the transcription start site
=+1
SENSE PRM
--- -------- -- ------- ----------
M1uI
-
CGACGCGTAG TACAGCTATG GATCTGTTCC TCTGGGGCAC ATGCACCTCT
TTGGCCCTGA GGTTTTCTCT CTTGCAGCAC GAAGACCTCC ATTCCCCACA
101 TTACAGGCTA GCCCCAAGT CCTTGGTTCC AGGGGCACAG TTTTATCTAA
151 ATACAGGTTC TTGCTAAGCA AGCAGAGACT GCTGATCTCC CCGGCTGAGT
201 CTGTGCAGCT GCCTCCAGTC CTGAACTTTC TCTGCTGGGA TGAGCAGAGT
251 TCACGCTCGG CTGAACTCGT GACTGTGTCA ACAGGGGGCA TGAAGATCAG
301 CACCAGGCAA AGGTGAGCGG AGTGCACAAG AATGAGGCAG AGACCTTTGG
351 GACAAGAGT TCCCCACCCG TGGGGCCATC ACTGCATGGA CGCTGA TGCC
401 AGGATAGGGC TGGATGGAAT ATGCTGCACC ATCTCCCTGT TGGAGAGCAG
451 ACACATTCCT TTGCCTCTGC CTCTCCGCTC AGTGCCAGCT CTGCAACGTG
M1uI
------
501 CCCGCTAAT AAGTTAGCC CTATCAAGAC CGACGCGT
- -  - -  - - -   -     - - -- - - --   
ANTISENSE PRM
